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Abstract 
The technology of Microarray is among the vital technological advancements in bioinformatics. 
Usually, microarray data is characterized by noisiness as well as increased dimensionality. 
Therefore, data, that is finely tuned, is a requirement for conducting the microarray data analysis. 
Classification of biological samples represents the most performed analysis on microarray data. 
This study is focused on the determination of the confidence level used for the classification of a 
sample of an unknown gene based on microarray data. A support vector machine classifier 
(SVM) was applied, and the results compared with other classifiers including K-nearest neighbor 
(KNN) and neural network (NN). Four datasets of microarray data including leukemia data set, 
prostate dataset, colon dataset, and breast dataset were used in the research. Additionally, the 
study analyzed two different kernels of SVM. These were radial kernel and linear kernels. The 
analysis was conducted by varying percentages of dataset distribution coupled with training and 
test datasets in order to make sure that the best positive sets of data provided the best results.  
The 10-fold cross validation method (LOOCV) and the L1 L2 techniques of regularization were 
used to get solutions for the over-fitting issues as well as feature selection in classification. The 
ROC curve and a confusion matrix were applied in performance assessment.  K-nearest neighbor 
and neural network classifiers were trained with similar sets of data and comparison of the 
results was done.  The results showed that the SVM exceeded the performance and accuracy 
compared to other classifiers. For each set of data, support vector machine was the best 
functional method based on the linear kernel since it yielded better results than the other 
methods. The highest accuracy of colon data was 83% with SVM classifier, while the accuracy 
of NN with the same data was 77% and KNN was 72%.  Leukemia data had the highest accuracy 
of 97% with SVM, 85% with NN, and 91% with KNN. For breast data, the highest accuracy was 
73% with SVM-L2, while the accuracy was 56% with NN and 47% with KNN.  Finally, the 
highest accuracy of prostate data was 80% with SVM-L1, while the accuracy was 75% with NN 
and 66% with KNN.  It showed the highest accuracy as well as the area under curve compared to 
k-nearest neighbor and neural network in the three different tests. 
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Chapter 1 
Introduction 
1.1 Introduction to Bioinformatics 
Bioinformatics is an evolving field that has risen from its incorporation in biology, mathematics 
and computer science. It mainly involves inception, management and examination of biological 
data mainly obtained from a substantive number of experimental test runs that may at times 
provide large data set. To this effect, there is need to establish comprehensive mechanisms to aid 
in the interpretation and processing this data and consequently producing accurate information 
that is needed for research and study purposes [1]. This led to the inception of bioinformatics, a 
discipline that integrates both biology and computer science. 
Changes in the field of bioinformatics have encouraged numerous analysts in investigating the 
information and comprehension of the structural, comparative and practical properties. A 
significant percentage of the improvements have been investigation of genomes and proteins, 
recognizing metabolic and flagging pathways which characterize the genetic connections, 
advancement of microarray chip and leading microarray analyses to gauge the genetic 
articulation levels. The accessibility of the information on open sites and vaults made it simpler 
to do the research on such databases for instance, the National Center for Biotechnical 
Information (NCBI), is freely accessible for the scientists. NCBI gives organic information 
including DNA and protein arrangements and sways analysts to help their groupings to the 
database. Likewise, to process the information, finely tuned calculations were created throughout 
the years and have been made openly accessible. Some of them are BLAST and CLUSTALW 
calculations that perform grouping examination. Calculations to perform phylogenetic 
examination were additionally made accessible in general sites [2]. 
The development of the microarray technology can be depicted as the most fundamental 
innovation in the field of bioinformatics. This kind of technology is significant in the 
determination of values with respect to more than a thousand genes in a simultaneous manner. 
The expression values can be subjected to a number of experimental test runs to ascertain the 
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imperativeness of the tissues from which the genes were removed. One of the global acclimated 
methodologies of such classification is using the expression values of the genes that are derived 
from the microarray experiment. The study in this thesis are more focused on ascertaining the 
confidence levels in making classifications on the unknown gene sample based on microarray 
data by using the Support Vector Machines (SVM).  There was the need to come up with a brief 
explanation on gene expression and microarray technology. This will help greatly in providing 
for an in depth comprehension of the problems that exist in the current classification 
mechanisms. Successively, a brief introduction is given on support vector machines, K-nearest 
neighbor and neutral network classifiers. 
1.2 Gene Expressions and Microarrays 
1.2.1 Understanding gene expressions 
"Gene expression is the term utilized for portraying the interpretation of data contained inside the 
DNA, the storehouse of hereditary data, into messenger RNA (mRNA) atoms that are then 
interpreted into the proteins that perform a large portion of the discriminating capacity of cells" 
[3]. Gene expression is a complex process that permits cells to respond to the changing inward 
prerequisites and furthermore to outside ecological conditions. This system controls which genes 
to express in a cell and furthermore to build or reduce the level of expression of genes. 
1.2.2 Analyzing gene expression levels 
The expression levels of the genes can be directly correlated to the characteristics and behavior 
of the species.  Research in the field of bioinformatics proposes that the reasons for a few 
variations from the norm are due to the change in the level of representation of qualities from the 
typical level.  With the assistance of new age advances, we are presently ready to study the 
interpretation levels of a huge number of genes immediately.  Along these lines, we can attempt 
to compare the articulation levels in normal and abnormal states.  The outflow values in 
influenced qualities can help us measure them with normal representation qualities and thereby 
provide an explanation about the variation from the norm.  The quantitative data of quality 
interpretation profiles can help support the fields of medication improvement, judgment of 
ailments and further understanding the working of living cells.  A quality is viewed as 
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educational when its statement serves to arrange examples to an ailment condition. These 
educational qualities help us create grouping frameworks, which can recognize typical cells from 
the unusual ones. Microarray is one such instrument that can be utilized to screen the statement 
level of qualities [17]. 
1.2.3 Introduction to Microarrays 
A microarray is a device used to study and record the gene expressions of a large number of 
genes at the same time.  A microarray comprises of distinctive nucleic acid probes that are 
artificially appended to a substrate, which can be a microchip, a glass slide or a microsphere-
sized globule [4].  There are distinctive sorts of microarrays, for example, DNA microarrays, 
protein microarrays, tissue microarrays and carb microarrays [5]. The microarray innovation was 
advanced out of the need to focus measures of specific substances inside a mixture of different 
substances. The process was first carried out using assays.  Assays were used in a variety of 
applications like identification of blood proteins, drug screening and so on. Immunoassays 
helped to focus the measure of antibodies bound to antigens in immunologic reaction forms. 
Fluorescent marking and radioactive naming were utilized to name either the antibodies or the 
antigens to which the antibodies were bound. The idea of immunoassays was later reached out to 
include DNA investigation. The most punctual microarrays included tests in which the 
specimens were spotted physically on test surfaces. The smallest attained spot sizes were 300 μ 
m. However, it was only when the spot sizes became smaller for accommodating more genes, 
that robotic and imaging equipment were deployed. Labeling methods involved using radioactive 
labels for known sequences. Another technique involved using fluorescent dyes to label 
biological molecules in sample solutions. The Southern Block technique developed later used 
arrays of genetic material for the first time.  The mechanism encompassed labeling the DNA and 
RNA strand to ascertain the rest of the nucleic acid that was attached to the solid surfaces. In this 
procedure, denatured strands of DNA were exchanged with nitrocellulose channels for 
recognition by hybridization of radioactively named tests. Such an exchange was conceivable in 
light of the fact that denatured DNA strands structured covalent bonds with robust surfaces 
without re-associating with one another. These however, effectively shaped bonds with 
corresponding sections of RNA [17]. Southern Block strategy utilized permeable surfaces as the 
robust backing for DNA strands. These were later supplanted by glass surfaces, which 
accelerated the substance responses since the substances did not diffuse into permeable surfaces.  
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In 1980 the Department of Endocrinology at the University of London utilized micro spotting 
methods to manufacture clusters for high affectability immunoassay studies including 
examination of antibodies in the field of immunodiagnostics. This procedure was later received 
in an extensive variety of uses including organically tying examines. The result of this strategy, 
known as multianalyte microspot immunoassays, measured radiometric power by taking the 
degree of the fluorescent signs to the absorbance. The innovation has been advancing after and a 
ton of exploration has been fulfilled to refine this system. The main DNA Microarray chip was 
built at Stanford University, though Affymetrix Inc. was the first to make the licensed DNA 
microarray wafer chip called the Gene Chip. Figure 1.1 demonstrates a run of the mill 
exploration of different avenues regarding an oligonucleotide chip. 
 
 
 
 
 
 
 
 
 
 
 
1.2.4 Distinct Types of Microarrays 
Microarrays can be divided into two types [7]: 
Figure 1.1 Microarray Chip. [6] 
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Single Channel or One Color Microarrays 
This innovation was initially presented by Affymetrix Inc. In these microarrays, individual 
samples are subjected through hybridization after it is named with a fluorescent color. These 
microarrays measure irrefutably the power of declaration. These are additionally called 
oligonucleotide microarrays where the tests are oligonucleotide successions that are 15 to 70 
bases long. Oligonucleotides are either, incorporated independently and spotted on the chips, or 
they can be orchestrated specifically on the chip utilizing as a part of silicon systems. The last 
procedure is completed utilizing a methodology called photolithography. Tests including one 
color microarrays are described by effortlessness and adaptability. Hybridization of a single 
sample per microarray not only helps to compare between microarrays but also allows analysis 
between groups of samples. 
Dual Channel or Two color Microarrays 
These are likewise termed as cDNA Microarrays. In these microarrays, example successions and 
ordinary arrangements are marked with two distinctive fluorescent colors. Both these DNA 
arrangements are hybridized together on the DNA Microarrays and a degree of fluorescence 
intensities emitted by the two colors is considered so as to assess differential representation level. 
This outline of microarrays was created to decrease variability blunder in microarray fabrication. 
Hybridization of two specimens to tests on same microarray takes into account immediate 
correlation. These microarrays are known to be very delicate and exact. Figure 1.2 demonstrates 
the convention for a microarray test. Tissue examines whose quality statements are to be 
measured have their mRNAs (delivery person RNAs) removed. At that point reverse 
transcriptase is connected to change over these mRNAs to cDNAs (correlative DNAs).  cDNAs 
are marked utilizing brilliant colors as per the specimen. At that point the example on the 
microarray chip is then subjected to hybridization. Amid hybridization the cDNAs tie to their 
reciprocal strands utilizing base pair holding. The chip is then washed to uproot unhybridized 
materials. Advanced picture is acquired by laser checking the chip. The picture is prepared 
utilizing information standardization and other picture transforming procedures to get the 
statement level of every quality focused around the fluctuating intensities of fluorescence. 
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1.2.5 Components of Microarray Technology 
A Microarray technology encompasses the following: 
The Array: 
This is the robust base on which the hereditary material of known arrangements are organized 
efficiently along lattices. The process of arrangement is called spotting. The array is made up of 
Figure 1.2 depicting the Microarray experiment protocol [8] 
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glass or nylon which bears a large number of wells to hold the distinctive Complementary DNA 
(cDNA) sequences. Each one spot on the microarray represents an independent experimental 
assay used to measure the presence and abundance of specific sequences in the sample strands of 
polynucleotides. The Arrays are comprised of glass, nylon and sometimes coated using silicon 
hydride. The covering empowers the microarrays to repulse water and supports hybridization of 
cDNA strands to the surface of the exhibit. It likewise keeps the polynucleotide tests from 
spreading, therefore holding commotion under wraps. 
Probes: 
The single stranded cDNAs that are spotted on the exhibits are known as “probes". The target 
polynucleotide groupings in the organic specimen arrangements are hybridized with the 
complimentary tests. Adherence of probe to the array is very crucial to maintain spot integrity and 
prevention of the probe from being washed away during array processing.  It is additionally critical as a 
spasmodically followed test can cause commotion to leak in subsequently decreasing the nature 
of resultant picture. After the test is spotted onto the show, it is air dried and presented to 
ultraviolet radiation to guarantee stability and solid adherence. 
The Spotter: 
These are mechanical instruments that apply the tests to the shows utilizing high exactness. The 
spotters apply each one spot to a framework on the exhibit. This aids in leading an expansive 
number of trials in parallel. The spotting is carried out utilizing either contact or non-contact 
strategies. Contact spotters have the spotting spout like an ink pen where connected weight 
discharges the tests on the shows. Non-contact spotters utilization ink-plane engineering or the 
piezoelectric narrow impacts for spotting purposes. Non-contact spotters are speedier than 
contact spotters; however contact spotters have more exactness as contrasted with non-reaching 
ones [10]. 
1.3 Automated Analysis of Microarray data 
Microarrays have made ready for analysts to assemble a great deal of data from a huge number 
of qualities in the meantime. The principle assignment is the investigation of this data. Looking 
at the size of the data retrieved from the genetic databases, we can definitely say that there is no 
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way to analyze and classify this information manually. In this thesis, an effort has been made to 
classify gene expression data of four different cancer datasets into two classes of different 
samples. This study tries to unveil the potential of classification by automatic machine learning 
methods. 
1.4 Classification Techniques 
In the current study, we deal with a classification problem which focuses on dividing the samples 
of four microarray datasets into two categories. Any classification method uses a set of 
parameters to characterize each object. These features are relevant to the data being studied. Here 
we are talking about methods of supervised learning where we know the classes into which the 
items are to be ordered. We likewise have a set of items with known classes. A training set is 
utilized by the order projects to figure out how to arrange the items into wanted classes. This 
training set is utilized to choose how the parameters ought to be weighted or consolidated with 
one another so we can separate different classes of articles. In the application stage, the trained 
classifiers can be utilized to focus the classifications of articles utilizing new examples called the 
testing set. The different well-known to order techniques are discussed as follows [11]. 
1.4.1 Support Vector Machine 
Support vector machine (SVM) is picking up prevalence for its capacity to arrange boisterous 
and high dimensional information. SVM is a measurable learning calculation that groups the 
examples utilizing a subset of preparing specimens called support vectors. The thought behind 
SVM classifier is that it makes a peculiarity space utilizing the qualities as a part of the training 
data. It then tries to distinguish a decision boundary or a hyper-plane that differentiates the 
gimmick space into two parts where every half contains just the preparation information focuses 
fitting in with a classification. This is demonstrated in Figure 1.3 
In Figure 1.3 the data points belong to one class and square points belong to another class. SVM 
tries to discover a hyper-plane (H1 or H2) that differentiates the two classifications. As 
demonstrated in figure there may be numerous hyper-planes that can separate the information. 
Taking into account "maximum margin hyper-plane" idea SVM picks the best decision boundary 
that differentiates the information. Every hyper-plane (Hi) is connected with a couple of 
supporting hyper-planes (hi1and hi2) that are parallel to the decision boundary (Hi) and pass 
through the closest information point. The separation between these supporting planes is called 
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as margin. In the figure, despite the fact that both the hyper-planes (H1 and H2) isolate the 
information focuses, H1 has a greater margin and has a tendency to perform better for the 
characterization of obscure specimens than H2. Subsequently, greater the edge is, the less the 
speculation blunder for the arrangement of obscure specimens is. Consequently, H1 is favored 
over H2.  
 
 
 
 
 
 
 
There are two sorts of SVMs, (1) Linear SVM, which differentiates the information focuses 
utilizing a linear decision boundary and (2) Non-linear SVM, which divides the information 
focuses utilizing a non-linear decision boundary. For a linear SVM the mathematical statement 
for the decision boundary is: 
                                    w · x + b = 0                                                             (1.1) 
where, w and x are vectors, b is a scalar and the bearing of w is perpendicular to the linear 
decision boundary. Vector w is dead set utilizing the preparation dataset. For any set of 
information focuses (xi) that lie above the decision boundary the mathematical statement is: 
                                                 w · xi+ b = k,               where k > 0,                                 (1.2) 
Figure 1.3: Decision boundary and margin of SVM classifier [46] 
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and for the data points (xj) which lie below the decision boundary the equation is 
                                                   w · xj+ b = k’,             where k’< 0.                                (1.3) 
By rescaling the values of w and b the equations of the two supporting hyper planes (h11and h12) 
can be defined as 
                                                  h11: w · x + b = 1                                                             (1.4) 
                                                  h12: w · x + b = -1                                                            (1.5) 
The distance between the two hyper planes (margin “d”) is obtained by 
                                                w · (x1– x2) = 2                                                                (1.6)  
                                                 d = 2/||w||                                                                        (1.7)  
The target of SVM classifier is to augment the estimation of d. This target is equal to minimizing 
the estimation of||w||2/2. The estimations of w and b are acquired by tackling this quadratic 
improvement issue under the requirements 
                                                w · xi+ b ≥ 1 if yi = 1                                                       (1.8) 
                                                 w · xi+ b ≤ -1 if yi = -1                                                    (1.9)  
where yi is the class variable for xi. Forcing these limitations will make SVM to place the 
preparation occurrences with yi = 1 above the hyper plane h11 and the training occasions with yi 
= -1 underneath the hyper plane h12. The optimization problem can be explained utilizing 
Lagrange multiplier method. The target capacity to be minimized in the Lagrangian structure can 
be composed as: 
                                               𝐿𝑃 = 12 ‖𝒘‖2 – ∑ ∝𝑖𝑁𝑖=1 (𝒘 .𝒙𝑖 + 𝑏) − 1                        (1.10) 
∝𝑖are Lagrange multipliers and N are the quantity of specimens [6]. The Lagrange multipliers 
ought to be non-negative (∝𝑖 ≥ 0). So as to minimize the Lagrangian structure, its halfway 
subordinates are acquired concerning w and b and are likened to zero. 
                                                      𝜕𝜕𝑃
𝜕𝒘
= 0 => 𝒘 =  ∑ ∝𝑖 𝑦𝑖𝒙𝒊𝑁𝑖=1                                    (1.11) 
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                                              𝜕𝜕𝑃
𝜕𝒘
= 0 => ∑ ∝𝑖 𝑦𝑖 = 0𝑁𝑖=1                                      (1.12)       
The mathematical statement is changed to its double structure by substituting the qualities from 
Equation 1.11 and 1.12 in the Lagrangian structure Equation 1.10. The double structure is given 
by: 
                                                         𝐿𝐷 =  ∑ ∝𝑖 −  12∑ ∝𝑖∝𝑗 𝑦𝑖𝑁𝑖=1 𝑦𝑗𝒙𝒊𝒙𝒋𝑁𝑖=1           (1.13) 
The preparation occurrences for which the estimation of αi> 0 lie on the hyper plane h11or h12 are 
called support vectors. Just these training cases are utilized to get the decision boundary 
parameters w and b. Henceforth the order of obscure examples is focused around the support 
vectors. At times it is desirable over misclassify some of training specimens (training error) to 
get decision boundary plane with most extreme edge. A decision boundary with no training 
mistakes however smaller margin may prompt over-fitting and can't group obscure examples 
accurately. Then again, a decision boundary with few training error and a bigger margin can 
group the obscure specimens all the more precisely. Subsequently there must be a tradeoff 
between the margin and the quantity of training error. The decision boundary along these lines 
acquired is called as soft margin. The demands for the optimization problem still hold great, 
however require the expansion of slack variables (ξ), which represent the soft margin. These 
slack variables relate to the mistake in decision boundary. Additionally a punishment for the 
training error ought to be presented in the target work so as to adjust the margin worth and the 
quantity of training error. The target capacity for the optimization problem will be minimization 
of: 
                 ‖𝒘‖2/ 2  + 𝐶 (∑𝜉𝑖)𝑘                                                           (1.14) 
Where C and k are specified by the user and can be varied depending on the dataset. The 
constraints for the optimization problem will be 
                     w · xi+ b ≥ 1 - ξi,             if yi = 1,                                      (1.15)  
                      w · xi+ b ≤ -1 + ξi,          if yi = -1.                                     (1.16) 
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The Lagrange multiplier for soft margin varies from the Lagrange multipliers of linear decision 
boundary. αi values ought to be non-negative furthermore ought to be less than or equivalent to 
C. Henceforth the parameter C act as the upper limit for error in the decision boundary [6]. 
Linear SVM performs well on datasets that can be effortlessly divided by a hyper-plane into two 
sections. Anyhow now and then datasets are perplexing and are hard to order utilizing a linear 
kernel. Non-linear SVM classifiers can be utilized for such mind boggling datasets. The idea 
driving non-linear SVM classifier is to change the dataset into a high dimensional space where 
the information can be divided utilizing a linear decision boundary. In the original feature space 
the decision boundary is not linear. The fundamental problem with changing the dataset to higher 
measurement is the increment in intricacy of the classifier. Additionally the precise mapping 
capacity that can separate data linearly in higher dimensional space is not known. Keeping in 
mind the end goal to conquer this, an idea called kernel trick is utilized to change the information 
to higher dimensional space. In the event that Φ is the mapping function, so as to discover the 
linear decision boundary in the changed higher dimensional space, attribute x in the Equation 
1.13 is supplanted with Φ(x). The changed Lagrangian double structure is given by: 
𝐿𝐷 =  ∑ ∝𝑖 −  12∑ ∝𝑖∝𝑗 𝑦𝑖𝑁𝑖=1 𝑦𝑗Φ(𝒙𝑖)Φ(𝒙𝑗𝑁𝑖=1 )                         (1.17) 
The dot product is a measure of similarity between two vectors. The key thought behind kernel 
trick is that it considers the dot product comparable to in the first and the changed space. 
Consider two data case vectors xi and xj the first space. At the point when changed to a higher 
measurement, they are changed to Φ(xi) and Φ(xj) individually. Similarly, the likeness measure 
in unique space is changed from xi • xj to Φ(xi) • Φ(xj) in higher measurement space. The dot 
product of Φ(xi) and Φ(xj) is known as the kernel function and is represented by K(xi, xj). As the 
kernel trick assumes that the dot products are comparative in both the spaces, it helps in 
registering the kernel function in the changed space utilizing the original attribute set. Henceforth 
the first nonlinear decision boundary mathematical statement in lower measurement space is 
changed to a comparison of linear decision boundary in higher dimensional space given by:  
                                      w · Φ (x) + b = 0                                                                           (1.18) 
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1.4.2 Neural Networks 
Neural Networks (NNs) have been effectively used in numerous fields: control field, speech 
recognition, medical diagnosis, signal and image processing, etc.  The main advantages of NNs 
include self-adaptivity, self-organization, real time operation, and so on. This model takes us an 
alternate methodology to critical thinking from that of ordinary machines. A NN is comprised of 
a set of artificial neurons which are called nodes, and they have associations called weight 
between them. The most straightforward structural planning of fake neural systems is single-
layered system, likewise called Perceptron, where inputs connect directly to the outputs through 
a single layer of weights. The most usually utilized type of NN is the Multi-layer Perceptron 
(MLP), see Figure 1.4. NNs offer a compelling and exceptionally general structure for speaking 
to non-linear mapping from a few information variables to a few yield variables [15]. 
 
 
 
 
 
 
 
 
 
 
In artificial neural network (ANN), there are several ways to updating the weights associated 
with the connections between the layers.  Most involve initializing the weights and are fed 
through the network.  The error made by the network at the output is then calculated and fed 
backwards through a process called "backpropagation". This process is then used to update the 
weights, and by repeated use of this process, the network can learn to distinguish between 
several different classes. The exact equations involved vary from case to case. More detail will 
be discussed in section 3.1.9. 
Figure 1.4: NN Multi-layer Perceptron (MLP) [15] 
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INPUT/OUTPUT UNITS, where each connection has a WEIGHT associated with it is given by 
the following transformation: 
𝑦𝑜𝑜𝑜 = 𝐹(𝑥,𝑊) 
where W is the matrix of all weight vectors. 
The input can be raw input data or the output of other perceptrons. The output can be the final 
result (e.g. 1 means yes, 0 means no) or it can be inputs to other perceptrons. 
1.4.3 K-Nearest Neighbor (KNN) 
KNN is a case based classifier. Classification of unknown samples is focused around the 
separation capacity. This sort of classification is executed by the area of the nearest neighbors in 
the instance space. Classifying the unknown samples is carried out by naming it with one of the 
names of the nearest neighbors. The estimation of K is the quantity of nearest neighbors that 
ought to be considered to group the obscure example. 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: working of KNN classifier [47] 
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Figure 1.5 is utilized to clarify the situation of KNN arrangement. It considers examples fitting in 
with two classes to be specific, diseased and normal. The unknown sample in the center needs to 
be classified either diseased sample or normal sample. The inward loop speaks to K=3 and the 
unknown sample has two neighbors from normal and one from diseased. In view of the greater 
part voting, the unknown sample will be classified as normal. On account of the external ring K 
= 5 and the unknown sample has two neighbors from normal and three from diseased and the 
majority voting will classify the unknown sample to be diseased. The nearest neighbor for an 
unknown sample can be found by figuring the distance function. Euclidean separation is the 
ordinarily utilized separation capacity. The usually utilized estimations of k are 3 and 5. At the 
point when the estimation of k is excessively vast, the execution of the classifier may diminish 
[17]. More detail will be discussed in section 3.1.10. 
 
1.5 Objectives of the study and outline of the thesis 
The specific objectives of the study were to: 
• Determine the confidence level in classifying an unknown gene sample based on 
microarray data using SVM comparing with two other classifiers. 
• Analyze two different kernels of SVM "linear kernels and the radial kernel" and 
determine the kernel and the parameters best suited for classification of a given 
microarray data. 
• Use different percentages of distribution of the dataset to training and testing datasets to 
ensure what should be positive dataset where we are receiving best result. 
• Use 10-fold cross validation (LOOCV method) and L1 L2 regularization technique to 
solve the over- fitting issues and feature selection in classification. 
• Use Confusion matrix and ROC curve used to evaluate the performance 
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The rest of this thesis is organized as follows 
1) Chapter 2 presents the literature review and some of the previous work done on the microarray 
classification using SVM, NN and KNN. 
2) Chapter 3 focuses on the datasets used in thesis, the process followed and application of the 
process model to the various datasets selected. 
3) Chapter 4 presents the results obtained from the analyses performed and discusses the results 
obtained. 
4) Chapter 5 concludes the report by presenting the observations derived from the current study. 
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Chapter 2 
Literature Review 
This section primarily analyses the prior works on the classification of microarray data utilizing 
the support vector machine (SVM), K-nearest neighbor (KNN), and neural networks (NN) 
classifiers. Prior works involve enhancing the classifiers for improved classification precisions. 
S. Mukherjee et al in [18] rendered classification on leukemia cancer data [1] utilizing SVMs. 
The project dissected classification competence of SVM over the high dimensional microarray 
data. They rendered the feature selection method propounded by Golub et al in [2]. They 
analyzed the features and selected top 49, 99 and 999 genes in order to meet the classification 
need. Classification of all the 7129 genes in dataset was rendered. The study propounded two 
different procedures; 1) SVM classification without negations; 2) SVM classification with 
negations. The former method was categorizing the dataset with the use of linear SVM classifier 
with the topmost 49, 99 and 999 genes and also making use of the other set of 7129 genes. The 
SVM classifier returned with better accuracy in comparison to the method proposed by Golub et 
al. The non-linear polynomial kernel SVM classifier didn’t enhance precision for the dataset. 
The second method made use of a confidence threshold value in order to negate the test samples 
if they reach near the boundary plane. Confidence threshold was measured using Bayesian 
formulation. Proximity of the training samples to the decision boundary was measured on the 
basis of leave-one-out fundamental. The allocation function judgment of the proximities was 
procured by using the non-parametric density estimation algorithm. Then the actual level for the 
classifier was procured by deducting the estimate from unity. Proximity between the test sample 
and the decision boundary was measured and if it resulted in less confidence height of the 
classifier then the verdict is negated and quality of the test sample cannot be analyzed. The 
general precision was 100% with some samples disallowed in every class of the filtered genes. 
Of the top 49 genes, 4 were not allowed. Similarly, 2 genes were disallowed from the topmost 99 
genes, no rejection from the topmost 999 genes and 3 genes were cancelled out of 7129 genes. 
They maintained that linear SVM classifier with rejections formulated on confidence values 
accomplished better on the leukemia cancer dataset [18]. 
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The study performed by Terrence S. Furey et al in [19] based on SVM classification technique in 
order to segregate the microarray data and also render validation of the cancer tissue sample. The 
experimental dataset was of 31 samples. These constituted of cancerous ovarian tissues and 
normal ovarian tissues along with normal non-ovarian tissues. They intended to segregate 
cancerous tissues from the normal tissues (which consisted of normal ovarian and normal non-
ovarian). Mostly the machine learning algorithms underperform for bigger number of features, 
whereas SVM can easily handle huge dimensional data. Therefore in the study entire dataset was 
used for bifurcation. The process consisted of bifurcation of the entire dataset using hold-one-out 
techniques. Then the features were arranged and the topmost features were eventually used for 
bifurcation. These features were arranged on bases of the scores, which can be measured as a 
ratio. The numerator of the ratio signifies the gap between the mean expression value of genes in 
normal tissues and tumor tissues. The denominator is calculated as the total of the standard 
deviation of normal tissues in addition with the tumor tissues. Linear kernel was used for 
classification. Then topmost genes on the basis of their scores are procured to train the SVM and 
unfamiliar samples are bifurcated. For the ovarian dataset two samples (N039 and HWB3) were 
wrongly classified time and again. They studied these samples by measuring the margin value, 
which they concluded as the proximity of the sample from the decision boundary. The margin 
value for misjudged sample N039 was comparatively huge interpreting that it may be labeled 
wrong. A precise study by the biologist cleared the doubt and indicated that the sample was 
marked wrong. Another misjudged sample HWBC3 was decided to be an outlier. Also topmost 
genes procured from feature selection, three out of five genes are associated with cancer. They 
decided that feature selection can be rendered to ascertain genes that are associated with cancer 
but implied that it is not 100 percent accurate as some genes that are not associated with cancer 
were also ranked incorrectly. To simplify the method they diligently analyzed leukemia dataset 
(Golub et al, 1999) and colon cancer dataset (Alon et al, 1999). The results were kindred to the 
prior results. They ascertained that SVM could be used for bifurcation of microarray data and 
results. They further realized that SVM could be useful in classification of microarray data and 
for studying the misjudged specimen. It has been thought out that with the use of non-linear 
kernel, bifurcation precision might be exalted for complicated dataset, which are generally 
arduous to bifurcate with the use of a simple linear SVM kernel [19]. 
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The study organized by Sung-Huai Hsieh et al [13] stressed on segregation of leukemia dataset 
with the use of support vector machines. They offered a SVM classifier using Information Gain 
(IG) as feature selection method. Information gain is the reduction in the entropy when the data 
is partitioned based on that gene. Entropy can be useful for assessing if a feature is beneficial in 
carrying out the bifurcation, in addition to defining the relation amongst the training dataset. 
Microarray dataset was sub-divided further into two independent sets – training and test data. 
Then training dataset undergoes feature selection by computing the IG values for the genes. 
Genes with higher rank IG values were chosen for segregation. Further the training data is 
prepared to take care of any outliers and reduce the learning model bias. This training data is 
then used to prepare SVM classifier. Radial-based function (RBF) kernel with grid searching was 
chosen in SVM model and accurate values for the parameters of RBF (penalty C and gamma g) 
were concluded. This model was put to test by arranging cross validation method and also by an 
independent test dataset. The paper propounded that SVM classifier model with IG feature 
selection rendered sufficient precision (98.10%) [13]. 
John Phan et al. debated regarding several parameter optimization techniques for SVM classifier 
so as to enhance segregation [14]. The study stressed on distinguishing genetic markers that can 
separate renal cell carcinoma (RCC) subtypes. The dataset constituted of different types 
including 13 clear-cell RCC, 4 chromophobe and 3 oncocytoma. The study strived to 
differentiate the clear cell RCC from the other two categories. Initially with the use of SVM, 
genes were ranked according to their capacity to differentiate classes. Then the prognostic 
precision was computed considering leave one out method. Sequential minimal optimization 
technique was put to use for enhancing SVM. It has been debated that precision developed by the 
SVM is largely dependent on the kernel selected and the parameters. The study stressed on linear 
and radial basis kernel (RBF).  The linear and RBF kernels have parameter ‘C’ that correlate to 
the penalty for incorrect classification. Higher intensity of ‘C’ means more penalties, making the 
classification model to be over-fitting. Conversely, smaller value of ‘C’ results in a more relaxed 
model that may find it tough to bifurcate the unfamiliar data correctly. In the paper, ‘C’ was 
varied from 0.01 to 10 for linear and 0.01 to 100 for the RBF kernel and thus the highest value of 
‘C’ was defined along with computing the prediction rate. On the basis of the average prediction 
rate collected by altering the parameters they propounded highest values for ‘C’ as 0.1 for linear 
kernel and 1 for RBF. Also the results indicated that the computed value of sigma resulted in 
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optimal average prediction rate. Similarly, the best value of sigma for the RBF kernel was 
propounded as the mean of closest 2m neighbors to the data point where m corresponds to the 
dimensionality of the data point. Also, the results indicated that the computed value of sigma 
obtained highest average prediction rate. It has been identified that the genes picked by the use of 
those specific processes were believed to have biological pertinence on the basis of gene 
ontology and literature [14]. 
Mihir Sewak [16] organized a study on bifurcation of leukemia dataset with the use of committee 
neural networks. In the study, a panel of neural networks was built to bifurcate samples of 
leukemia. Two types of classifications were propounded namely, binary classification and three 
class classification. For binary classification, the samples were divided into Acute 
Lymphoblastic Leukemia and Acute Myeloid Leukemia. For three class classification, the panel 
distinguished Acute Lymphoblastic Leukemia further into sub categories. Dataset was exposed 
to different preprocessing steps which resulted in obtaining more informative genes. Further 
these genes were put to use training various neural networks. The excelling neural networks were 
chosen over the others and selected into the committee. Part of the original dataset helped 
validating the committee and. the committee produced a staggering precision of 100% for binary 
classification and 97% for three class classification. 
Huilin Xiang et. al. [20] study stresses on the kernel based distance metric learning classification 
for microarray data. Data was classified using the maneuvered KNN method. This method 
constituted the kernel optimization for binary and multi class data. Then the metric distance 
procured by kernel optimization method exalted the ability of separating the class of data in 
feature space.  
The chosen method enhanced the workability of KNN classifier for the bifurcation of gene 
expression data. Smaller training data had rendered the algorithm unfit for working. To surpass 
this issue they had chosen an affected re-sampling method to enhance the size of the training data 
sample. This altered KNN method bifurcated leukemia dataset with an optimal precision of 96% 
and it was comparable with the workability of SVM classifier. 
Manik Dhawan [17] propounded the study on leukemia cancer dataset through committee 
approach. KNN classifier was put to use for bifurcation. The dataset had 48 ALL and 25 AML 
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samples. The dataset was randomized by choosing a validation set from the main dataset and 
used the remaining dataset to select the committee of classifier to classify the validation set. 
Random selection of 10 ALL and 10 AML samples were chosen for forming Training and 
testing datasets. 
Training and testing datasets were preprocessed and the dataset values were normalized between 
-1 to 1. Further these training and testing datasets were bifurcated into 5 different groups. The 
first group constituted 50 topmost genes and the secondary group had the next subsequent top 50 
genes and so on. Each training and testing groups were granted to four classifiers KNN (3,2), 
KNN (5,3), KNN (7,4), KNN (9,5). The most optimal working classifier from every group was 
selected into the committee.  The committee was brought to power by the use of validation sets. 
100% precision was achieved for 7 out of 12 validation sets which assured the soundness of the 
committee. 
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Chapter 3 
Materials and Methods 
The goal of this study is to determine the confidence level in classifying an unknown gene 
sample based on microarray data using SVM and comparing the results with two other 
classifiers. The study also provides analysis of two different kernels of SVM, namely “linear 
kernels and the radial kernel." Further this research focuses on determining the kernel and the 
parameters best suited for classification of given microarray data. The analysis was performed 
using different percentages of distribution of the dataset for training and testing datasets to 
ensure the best positive dataset that gives the best results. Ten-fold cross validation (LOOCV 
method) and the L1, L2 regularization techniques are processed to solve the over-fitting issues 
and feature selection in classification. A confusion matrix and ROC curve is used to evaluate the 
performance. 
3.1 Methodology 
3.1.1 Dataset selection 
Four different microarray datasets are used in the study: i) Colon cancer dataset by Alon et al. 
obtained from Princeton University Gene Expression Project. [23]; ii) Leukemia cancer dataset 
by Golub et al, obtained from Broad Institute [22]; iii) Breast cancer dataset by van’t Veer et al, 
obtained from NCBI [24]; iv) Prostate cancer dataset by Singh et al. [25]. 
Dataset of Colon Cancer 
An Affymetrix Hum6000 array of oligonucleotide was used for the purpose of analyzing the 62 
samples, including 20 normal samples and 40 tumor samples, collected from patients of colon-
cancer. Expression of 2000 genes along with the maximum lower strength across all the 62 
tissues was included in the matrix I2000. The genes were arranged in the descending order of 
lowest strength. Every entry in I2000 is gene intensity derived from around 20 particular pairs of 
the gene present on the chip and is received through filtering. In this study, 40 samples which are 
marked as negative have been collected from tumors and 22 samples, marked as positive have 
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been collected from biopsies of the healthy part of the colon of the same individuals. A total of 
two thousand genes were picked from 6500 depending on the measured level of expression [23].  
The format of the dataset is shown in table 3.1. 
 
 
 
 
 
 
 
 
 
 
 
Dataset of Leukemia 
High density oligonucleotide based microarrays were used for creating Leukemia dataset. These 
microarrays were made by Affymetrix and includes profiles of gene expression for two samples, 
ALL and AML collected from tumors. The received dataset was already segregated into test data 
and training data. The total dataset has 25 AML samples and 48 ALL samples; and for each of 
the sample there are a total of 7129 genes. Each of the samples used in the experiment included 
two columns linked by the microarray dataset. The level of expression of the gene in the 
microarray experiment is presented in the first column. The second column, represented by 
CALL determines whether the expression value is due to the gene or due to noise. It might take 
Table 3.1: Format of Colon cancer dataset  
 
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 
 
H55933 8589.4163 9164.2537 3825.705 6246.4487 3230.3287 …….. 
R39465 5468.2409 6719.5295 6970.3614 7823.5341 3694.45 ……. 
R39465 4263.4075 4883.4487 5369.9688 5955.835 3400.74 ……. 
R85482 4064.9357 3718.1589 4705.65 3975.5643 3463.5857 ……. 
U14973 1997.8929 2015.2214 1166.5536 2002.6131 2181.4202 ……. 
R02593 5282.325 5569.9071 1572.1679 2130.5429 2922.7821 ……. 
T51496 2169.72 3849.0588 1325.4025 1531.1425 2069.2463 ……. 
H80240 2773.4212 2793.3875 1472.2587 1714.6312 2948.575 ……. 
………. ………. ………. ………. ………. ………. ……. 
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any of the three values: presence, marginal or absence, represented by P, M and A according to 
the signal [22]. The format of the dataset is shown in table 3.2 
Table 3.2: Format of Leukemia cancer dataset 
 
Dataset of Breast Cancer 
Breast cancer microarray study performed by van’t Veer et al. released this gene expression data 
[24]. Seventy eight (78) primary samples of breast cancer were collected from patients over 55 
years of age with lymph node negative; 34 samples out of these 78 were from patients who 
within 5 years had grown distant metastases, and the rest 44 were from patients who were free 
from the ailments after at least a period of 5 years. Utilizing the fluorescent dye reversal 
technique, two hybridizations are done for each tumor on the microarrays. And the microarrays 
are containing almost 25000 human genes. Inkjet oligonucleotide method synthesized these 
genes.  Level of gene expression is numbered as 24188. Few missing values are included in this 
Accession 
Number 
Sample 1 CALL Sample 2 CALL Sample 3 
 
A28102_at 151 A 484 A 118 ……….. 
AB000114_at 72 A 61 A 16 ………. 
AB000115_at 281 A 118 A 197 ………. 
AB000220_at 36 A 39 A 39 ………. 
AB000381_s_at 29 P 38 A 50 ………. 
AB000409_at -299 A -11 A 237 ………. 
AB000410_s_at -336 A -116 P -129 ………. 
AB000449_at 57 P 274 P 311 ………. 
………. ………. ………. ………. ………. ………. ………. 
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data set.  Depending on the correlations between the gene expressions, remaining missing values 
are estimated.  This thesis focused on 4948 number of genes from 24188 genes in 78 tumor 
samples. Table 3.3 shows the formatted dataset. 
Table 3.3: Format of Breast cancer dataset 
Probe Set ID Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 … 
Contig45645_RC -0.125 -0.27 -0.141 -0.149 -0.382 … 
Contig44916_RC 0.07 0.123 0.025 0.068 0.064 … 
D25272 -0.006 0.056 -0.031 -0.084 0.033 … 
J00129 -0.575 -0.499 -0.465 -0.557 -0.873 … 
Contig29982_RC -0.585 -0.402 -0.533 -0.595 -0.474 … 
....… …. … …. … … …  
Dataset of the Prostate cancer 
Singh et al. (2002) present the Gene expression data containing 6033 genes for 102 samples from 
the microarray analysis and measurements of the individual gene expression.  102 samples 
include 50 healthy men and 52 patients of prostate cancer. Healthy samples are marked as 
“healthy” and diseased samples are labeled as “cancer” [25].The format of the dataset is shown 
in table 3.4. 
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Table3.4: Format of Prostate cancer dataset 
 
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 …. 
AFFX-MurIL2_at -9 -2 -6 0 -1 …. 
AFFX-MurIL10_at 1 1 17 9 0 …. 
AFFX-MurIL4_at 15 4 29 19 5 …. 
AFFX-MurFAS_at -2 -2 4 -10 0 …. 
AFFX-BioB-5_at -3 -5 -11 -18 -4 …. 
AFFX-BioB-M_at 4 0 -8 -18 1 …. 
AFFX-BioB-3_at 8 8 10 5 6 …. 
AFFX-BioC-5_at -12 -5 -24 -33 -4 …. 
AFFX-BioC-3_at -12 -9 -32 -31 -9 …. 
AFFX-BioDn-5_at 20 7 -20 14 12 …. 
AFFX-BioDn-3_at -6 -4 -11 -12 -5 …. 
AFFX-CreX-5_at 0 0 3 -2 0 …. 
…. …. …. …. …. …. …. 
 
3.1.2 Overview of the Procedure 
An overview of the procedure adopted in the study is given in the Figure 3.2. The following 
steps describe the procedure: 
1- The complete dataset was used to generate training and testing dataset randomly. 
2- Four different splits for the data samples were used for training dataset and test dataset 
respectively.  
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3- Training datasets were subjected to preprocessing which helped in the removal of genes 
that did not contribute to the classification. 
4- After preprocessing the data, feature selection was performed and filter method used to 
choose the informative genes. 
5- Samples in test dataset were classified using SVM with two different Kernels with 10-
fold cross validation. 
6- The test error was obtained between linear kernel and radial kernel, and linear kernel was 
chosen. 
7- The accuracy of classification was calculated and is displayed by confusion matrix. 
8- ROC curve and AUC (area under the curve) was calculated to evaluate the classifier. 
9- All steps were repeated four times with different split for the dataset each time with 
different percentage. 
10- After analyzing the results, L1 and L2 regularization with SVM was used to improve the 
accuracy with some dataset. 
 
 
 
 
 
 
 
Complete dataset  60% Train 40% Test  
70% Train 
30% Test  
80% Train 
20% Test 
 
90% Train 
10% Test 
 
First Time Second Time Third Time Fourth Time 
Figure 3.3.a Block diagram of Selection training and testing 
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Dataset selection 
Feature selection 
Analyzing the results 
Training SVM with linear and 
radial kernel 
Selection of training and testing datasets 
Data preprocessing 
Display confusion matrix  ROC curve & AUC 
L1 L2 SVM use to improve the results with some data 
Compare SVM accuracy with KNN and NN 
The process 
was repeated 
4 times with 
changing to 
the dataset 
disruption 
Figure 3.2 Protocol used for the current study 
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3.1.3 Selection of training and testing dataset 
The process followed for the dataset selection is shown in Figure 3.3.  For each of the 4 datasets, 
the complete dataset was used to generate training and test data randomly. Different percentages 
of distribution of the dataset were chosen.  The distribution selected were ((60:40)%, (70:30)%, 
(80:20)%, (90:10)%) for training dataset and test dataset respectively. For generating test data in 
first distribution, 40% samples from each category were picked from the entire dataset. The rest 
of the 60% samples in the dataset formed the training dataset.  In second distribution, 30% 
samples for test data and 70% samples for training dataset were selected.  In third distribution, 
20% samples for test data and 80% samples for training dataset were selected.  In fourth 
distribution, 10% samples for test data and 90% samples for training dataset were selected. ROC 
graph and area under the curve representing exactly what should be positive dataset shows the 
best results among different split ratios.  The process of generating the dataset was performed in 
R program and the R code is presented in Appendix A. The training and test data sample 
distribution for each of the 4 data sets is shown in Table 3.5.     
 
 
 
 
i = ( (60:40)% , (70:30)% , (80:20)% , (90:10)% ) 
Figure 3.3: Selection of training and testing datasets 
 
 
Dataset 
Complete dataset use for SVM 
% i Train  % i Test  
Repeated 4 
times with 
different split 
of the 
samples  
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Table 3.5: Sample’s distribution of training and test data for 4 datasets 
dataset  %60: %40 %70: %30 %80: %20 %90: %10 
Leukemia 
 
Train 
All AML Total All AML Total All AML Total All AML Total 
13 31 44 36 15 51 40 18 58 44 21 65 
Test 16 12 28 11 10 21 7 7 14 3 4 7 
Colon 
 
Train 
Tumor Normal Total Tumor Normal Total Tumor Normal Total Tumor Normal Total 
26 12 38 29 15 44 34 16 50 37 19 56 
Test 14 10 24 11 7 18 6 6 12 3 3 6 
Breast 
 
Train 
DM NODM Total DM NODM Total DM NODM Total DM NODM Total 
20 27 47 24 31 55 28 35 63 31 40 71 
Test 14 17 31 10 13 23 6 9 15 3 4 7 
Prostate 
 
Train 
Healthy Cancer Total Healthy Cancer Total Healthy Cancer Total Healthy Cancer Total 
31 31 62 37 35 72 42 40 82 44 48 92 
Test 19 21 40 12 18 30 8 12 20 6 4 10 
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3.1.3 Preprocessing of Data 
Preprocessing was done over the full datasets. Steps are as follows:  
• Preprocessing involved refurbishing the dataset by eliminating the housekeeping genes 
namely, the endogenous control genes. Housekeeping genes are responsible for basic 
cellular activities. Expression of these genes remains the same in every cell with minor 
changes. There is no role of these genes in classification. Therefore it is better to remove 
them from dataset [26]. 
• In the leukemia dataset following  the analysis of Adarsh Jose et al [27], genes having 
CALL values labeled as (A) or Absent in comparison with (P) or present were 
eliminated. Like the breast cancer, there is no mention about the CALL value in prostate 
as well as colon cancer. In those cases, all the genes were considered for further 
processing.  
• Expression values are affected by the background errors and it is reflected in the extreme 
values. Such values are known as outliers. Values above 16,000 cannot be measured by 
the imaging equipment. Below 20 values are also caused from the background noise [28, 
29]. For dealing with these outliers, there is a need of performing fundamental 
transformations. The data are winsorized by the transformation keeping the minimal 
value around 100 and maximum value around 16000. 
 
3.1.4 Feature selection 
The feature selection methods fall into two categories filter methods and wrapper methods [31].  
Filter was applied to the test dataset genes to know which genes are most relevant to the binary 
classification task and these genes were selected to remove noisy or irrelevant genes. R program 
for preprocessing, transformations and filtering the data is presented in Appendix B. 
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3.1.5 Training the SVM 
One of the most reliable and standard data mining and machine learning tool was Support Vector 
Machines or (SVMs) [32]. Numbers of effective and impactful applications have been implied 
for classifying the microarray gene expression data. In order to use SVMs for classifying the 
gene expression data, let us assume M is the provided vectors of gene expression, and kernel 
function is denoted by K as shown in Equation 3.1. More importantly, it is frequently chosen as a 
polynomial of degree d. 
𝐾(𝑀,𝑚𝑖) = (𝑚𝑇𝑚𝑖 + 1)𝑑                                             (3.1) 
Following is the discriminant function 
𝐿(𝑀) = ∑ ∝𝑖 𝑐𝑖𝐾(𝑀,𝑚𝑖)𝑇𝑖=1                                             (3.2) 
Where 𝑚𝑖=1𝑇 is a set of gene vectors and 𝑐𝑖=1𝑇  is the corresponding class, ∝𝑖 is the weight of 
training sample yi. It signifies the strength of the sample with which it is embedded in the 
function of final decision. Only a part of the training vectors will be associated with a non-zero 
∝𝑖. These vectors are so-called support vectors. In order to increase the gap between the samples 
from two respective classes, training process needs to update the weights. 
𝐹(𝑎) = ∑ ∝𝑖 �2 − 𝛽𝑖𝐿(𝑚𝑖)� = 2∑ ∝𝑖𝑇𝑖=1 − ∑ ∑ ∝𝑖∝𝑗 𝛽𝑖𝑏𝑏𝑏𝑎𝑖𝐾(𝑦𝑖,𝑦𝑗)𝑇𝑗=1𝑇𝑖=1𝑇𝑖=1   (3.3) 
where ∝𝑖≥ 0. 
In this study preprocessed training data was utilized for training the model of the SVM classifier. 
R implementation of SVM classifier in e1071 package was utilized for training the SVM model. 
Two different kernels were utilized to train the SVM model, linear kernel and Gaussian radial 
basis function (RBF). Linear kernel function maps the examples in the training data onto a 
feature space and decides the ideal maximal margin hyper-plane that partitions both classes of 
data. The function utilized for linear kernel is 
                                       𝐾�𝑋𝑖 ,𝑋𝑗 � =  𝑋𝑖 .𝑋𝑗𝑇                                                              (3.4) 
Where "•" implies the dot product between the two vectors. In a Gaussian RBF kernel the data 
samples are changed to a high dimensional space most likely to an infinite dimensional space 
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where the data belonging to two categories can be separated utilizing a linear hyper-plane. The 
kernel function utilized for RBF is: 
𝐾�𝑋𝑖 ,𝑋𝑗 � = exp �−𝛾 �𝑋𝑖 − 𝑋𝑗�2� , 𝛾 > 0                          (3.5) 
γ is the kernel parameter. A default estimation of 1 was picked for g. As aforementioned, 
deciding an ideal hyper-plane is an optimization concern. Quadratic programming optimization 
technique was utilized for deciding the separating hyper-plane.  The SVM classifier was trained 
utilizing the data and the known classes of the training data. Information given to the SVM 
classifier was changed by varying the kernel function utilized by the SVM classifier. Test error 
was computed for every Kernel capacity with 10- fold cross validation. According to the test 
error results, linear kernel was selected. Appendix C shows training the SVM classifier with 
Linear Kernel and radial Kernel. 
3.1.5 Linear Kernel SVM 
After choosing the kernel to use, the training error is computed by applying the model to the data 
on which it is trained.  R code is presented in Appendix A. 
> predicted <predict(svm1,Xm) 
Predict function used to choose the best model on test set. When we use a linear kernel, there are 
no kernel parameters to specify. The only value we have to choose is the misclassification cost. 
Default is cost=1, but another value achieves better cross-validation results [34]. We tune the 
SVM by trying different values of cost with 10-fold cross-validation.  We employ cross-
validation to see what the cross-validated training set error rate is. 
ranges = list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100))) 
the cost list contain the value of misclassification cost. 
Once we know the best parameter setting, we can use it to learn an SVM. These two steps 
(finding best parameter and then training an SVM) are combined in the function tune.out, which 
returns the SVM with the best parameters. 
>tune.out = tune(svm, y~., data=df.train, kernel="linear", decision.values=TRUE,ranges = 
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list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100))) 
Then we choose the best model from 10 –fold cross validation 
>bestmod = tune.out$best.model 
summary function use to display detailed of performance results. 
>summary(bestmod) 
Next we use the best model on the training set to predict the class of samples in the test set. 
ypred = predict(bestmod, df.test, decision.values=TRUE) 
bestmod to use the best model to predict on test set,df.test test set. 
( tbl = table(predict=ypred, truth=df.test$y) ) 
 
3.1.6 Evaluated methods 
Confusion Matrix 
After we use the best model to predict on test dataset, a confusion matrix is used for evaluating 
the classifier according to their performance. Confusion matrix is termed as error matrix. It is a 
tabulated presentation that reveals algorithm performance. It is basically a supervised learning 
method. Confusion matrix shows the information regarding predicted and actual classifications 
performed following a classification system. Instance of the predicted class is reflected by the 
columns while the actual class is reflected by the rows. This name originated from the concept 
that whether the system confuses two classes or not. 
Suppose we use our classifier on a test set of labeled tuples. P is the number of positive tuples 
and N is the number of negative tuples. For each tuple, we compare the classifier’s class label 
prediction with the tuple’s known class label. The following definitions are used for evaluation 
measures [39]. 
True positives (TP): These refer to the positive tuples that were correctly labeled by the 
classifier. Let TP be the number of true positives. 
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True negatives (TN): These are the negative tuples that were correctly labeled by the classifier. 
Let TN be the number of true negatives. 
False positives (FP): These are the negative tuples that were incorrectly labeled as positive. Let 
FP be the number of false positives. 
False negatives (FN): These are the positive tuples that were incorrectly labeled as negative. Let 
FN be the number of false negatives. 
Table 3.6 shows the confusion matrix, which is used to analyze how well the classifier can 
recognize tuples of different classes.  
 
                           Table 3.6: Confusion matrix  
              Predicted Class 
 
Actual class 
 Yes No Total 
Yes 
No 
TP 
FP 
FN 
TN 
P 
N 
Total P’ N’ P+N 
 
Several evaluation measured have been defined for the confusion matrix.  
• The accuracy of a classifier on a given test set is the percentage of test tuples that are 
correctly classified by the classifier. It is given as: 𝑎𝑐𝑐𝑎𝑎𝑎𝑐𝑦 =  𝑇𝑃+𝑇𝑁
𝑃+𝑁
 
• The error rate or misclassification rate of a classifier M is 1 – accuracy(M) and is 
computed as: 𝑏𝑎𝑎𝑒𝑎 𝑎𝑎𝑏𝑏 =  𝐹𝑃+𝐹𝑁
𝑃+𝑁
 
• Sensitivity is the true positive rate, i.e., the proportion of positive tuples that are correctly 
identified and is given as: 𝑠𝑏𝑠𝑠𝑠𝑏𝑠𝑠𝑠𝑏𝑦 =  𝑇𝑃
𝑃
 
• Specificity is the true negative rate, i.e., the proportion of negative tuples that are 
correctly identified and is given as:  𝑠𝑠𝑏𝑐𝑠𝑒𝑠𝑐𝑠𝑏𝑦 =  𝑇𝑁
𝑁
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• Precision is a measure of exactness, i.e., percentage of tuples labeled as positive and is 
given as: 𝑠𝑎𝑏𝑐𝑠𝑠𝑠𝑒𝑠 =  𝑇𝑃
𝑇𝑃+𝐹𝑃
 
• Recall is a measure of completeness, i.e., percentage of positive tuples and is the same as 
sensitivity or the true positive rate and is given as:𝑎𝑏𝑐𝑎𝑟𝑟 =  𝑇𝑃
𝑇𝑃+𝐹𝑁
=  𝑇𝑃
𝑃
 
R code for computing the confusion matrix is presented in Appendix D. 
 
ROC curve 
In order to observe the performance of classifiers, we use ROC curve. ROC graph is 
accompanied with data mining for observing the performance of classifiers, for comparing them 
and is also useful in other cases where: 
• There are unequal class distributions 
• Different costs of misclassification 
False positive rate is plotted on the X-axis and true positive rate is plotted on the Y-axis in the 
ROC graph. In this graph perfect classifier is (0,1) and it has been found that both positive and 
negative cases are classified by this classifier. In (0,1), 1 stands for true positive rate and 0 stands 
for false positive rate. Besides this, (0,0) point signifies all negative cases, whereas (1,1) 
represents every positive case. In all the classification, point (1,0) is found as incorrect. Several 
cases are like that where parameter is adjustable for increasing TP at an increased cost of FP or 
even decreased cost of FP while TP is also decreasing. Pair of (FP, TP) is provided by each 
parameter setting and for plotting ROC curve, it has an effective application. Once we got the 
area inside the curve, we did comparison study with other classifiers.  R code for plotting ROC 
curve and AUC (area under curve) is presented in Appendix E. 
3.1.7 L1, L2-Regularization 
In the field of machine learning problem regularization is defined as a method in which extra 
information is introduced to avoid over-fitting [40]. This information is added in a restrictive 
format discouraging non-essential complexity, an example of which is setting a minimum 
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specification for smoothness or bounds on the vector space norm. The main use of regularization 
in machine learning is to help in the process of model selection keeping in mind that over-fitting 
has to be discouraged by rejecting any model that has violated the set specifications. L1 and L2 
regularization are the most common variants in machine learning. These can be added to learning 
algorithms that minimize a loss function 
   𝐸(𝑋,𝑌)                                                                                    (3.6) 
by instead minimizing        
                               𝐸(𝑋,𝑌)+∝ ‖𝑤‖                                                                       (3.7) 
Here w has been assigned the value of model’s weight vector. ‖. ‖ is either theL1 norm or the 
squared L2 norm, and α is a free parameter that needs to be tuned empirically (typically by cross-
validation).The method of regularization finds its use in various fields like binary and multiclass 
logistic regression, neural nets, support vector machines, conditional random fields and matrix 
decomposition methods. If regularization is being used in neural nets then L2 regularization is 
known as “weight decay”. Amongst L1 and L2 regularization it is L1 that is more commonly 
used because it is more successful in delivering sparse models thus enabling feature selection to 
be done within the framework of the learning algorithm but a drawback of L1 is that it is not 
differentiable so it may need to be changed in learning algorithm especially algorithms which 
cater to gradient based learners. 
3.1.8 SVM with L1, L2 Regularization 
Analysis has proved that support vector mechanism (SVM) is a good classification and 
regression method, which efficiently uses machine-learning theories resulting in maximum 
possible predictive accuracy thus eliminating chances of data over-fitting. Standard SVM usually 
employs L2 as its regularization method. Good results are obtained if the data set is free of noise. 
In case the data set deals with many noise variables L1 regularization SVM is a better choice. In 
data training SVM algorithms, the penalty functions are already inbuilt so at times they give 
excellent performance but in other cases might yield unsatisfactory results. The weight of vector 
w is minimized by connection between weighted SVM’s and L1- SVMs  
       𝑚𝑠𝑠𝑠𝑚𝑠𝑚𝑏𝑤,𝑏,𝜉            12 ‖𝑤‖1 + 𝐶 ∑ 𝜉𝑖𝑖                                                                     (3.8) 
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subject to                       𝑦𝑖(𝑤𝑇𝑥𝑖 + 𝑏) ≥ 1 − 𝜉𝑖         ∀𝑠,    𝜉𝑖  ≥ 0   ∀𝑠.                           (3.9) 
A wrapper package known as R package (LiblineaR) is used in this study. LiblineaR is actually a 
linear data classifier, which has a database consisting of millions of examples and features. Both 
L2 regularization and L1 regularization can work in LiblineaR. The standout feature of 
LiblineaR is multi-class classification, cross-validation for model selection, probability estimates 
(logistic regression) or weights for unbalanced data.  R code for SVM with L1, L2 
Regularization is presented in Appendix F. 
 
3.1.9 Neural Networks 
Artificial Neural Networks (ANN’s) are computational models inspired by biological neural 
networks (the central nervous systems of animals, in particular the brain). These computation 
models help in studying functions that depend on analysis of many undefined inputs. Artificial 
neural networks are generally presented as systems of interconnected "neurons" which can 
compute values from inputs, and are capable of machine learning as well as pattern recognition 
thanks to their adaptive nature. The simplest example of ‘NN’ is a single layered network known 
as Perceptron which has a direct connection between inputs and outputs by a series of weights. 
Multi layered Perceptron (MLP) is the most widely used type of NN (Figure 1.4). Through the 
use of NNs an efficient and wide based framework is created for linear mapping of many input 
variables producing many output variables. In a NN each input is multiplied by a connection 
weight, which is denoted by Wn. Usually, the resulting products are added (Eq. 3.10) and entered 
into a transfer activation function to produce an output. 
𝑌𝑜𝑜𝑜𝑜𝑜𝑜 = 𝑒(∑ 𝑋𝑛𝑊𝑛)                                          𝑁𝑛=0 (3.10) 
Equation 3.11 depicts logistic sigmoid function, which is the most commonly used activation 
function.  
𝑔(𝑎) =  1
1+exp (−𝑎)                                                     (3.11) 
The outputs that are generated lie between 0 and 1 and the inputs vary from negative to positive 
infinity. If the final result to be achieved is a trained network then the weights of each unit 
should be such that the difference between the actual and desired output is minimized. 
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Practically, backpropagation algorithm (BP) is the most commonly used supervised learning 
algorithm. BP algorithm functions on the basis of a gradient descent technique where the 
gradient of errors functions is the deciding factor of the proportion of weight change.                                                                                                                                                                                                                                                    𝐸 =  1
2
∑ (𝑚0 − 𝑏0)2𝑛0                                                                    (3.12) 
𝑊𝑖𝑗(𝑏 + 1) = 𝑊𝑖𝑗(𝑏) − 𝜂 𝜕𝜕𝜕𝑊𝑖𝑖 + 𝛽(𝑊𝑖𝑗(𝑏) −𝑊𝑖𝑗(𝑏 − 1))                    (3.13) 
The symbols denote the following values ZO –real output from final layer node, t0 depicts desired 
output, Wij(t) stands for the weight from node i to j during tth iteration and actually denotes the 
two constants of learning rate and momentum rate. Gene expression data obtained by using ANN 
is being introduced based on sample filtering. Verification of the model can be done by 
simulation tests that utilized data sets from four microarrays and comparison was made with 
SVM and k nearest neighbor. 
 
 
 
 
The data used as input in NN classifier to program the model was the same preprocessed training 
data that was used with SVM. NN classifier’s R implementation (nnet) was used for NN model 
training. After the training and test dataset has been generated, the first step to be performed is 
the normalization of predicted value. Then the attribute of the dataset that is to be predicted is 
used. 
gdf<-data.frame (ALL=colonCA_trainSub$class,t(exprs(colonCa_trainSub))) 
colonCA_trainSub$classthis subset from train dataset. Then the training data is entered into the 
model. 
Data selection 
Selection of 
training and 
test datasets  
Data pre-
processing Feature selection Training NN Display confusion matrix 
Figure 3.4 Block diagram of NN 
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nn1<-nnet(y, data=df.train,size=5,decay=0.01,Max NWts= 6131) 
Then the test set is predicted 
Print (table(predict(nn1,new=df.test,type=”class”),y.test))) 
The final step is to calculate classification accuracy and plot area under the curve. Appendix G 
shows the R code for all NN procedures. 
3.1.10 K-Nearest Neighbor (KNN) 
One of the simplest classifications used at present is the K Nearest Neighbors (KNN). Bressan 
and Vitri were the first to use it in 1951 and it has undergone many modifications since then and 
new forms have emerged like the probabilistic nearest neighbor model (Holmes, 2002). There is 
no need of a training phase in the KNN method and the new sample’s class is taken as the most 
common class. In this case, decision function is determined by 
𝐿(𝑀) = ∑ ∝𝑖 𝑐𝑖𝑇𝑖=1 𝐾(𝑀,𝑚𝑖)                                    (3.14) 
where K denotes the set of neighbor closest to the new point x. The time complexity of this 
method is 0(N), where N is the number of training samples. The advantage KNN has over SVM 
is that it can deal with multi –class classification with the new point’s class decided by its 
neighbors.  A distance metric like Euclidean Distance (ED) (Eq.3.15) or the Cosine Coefficient 
(CC) (Eq.3.16) between two gene expression vectors is used to define the set of nearest 
neighbors. 
𝐸𝐸 = �∑(𝑚𝑖 −𝑚𝑗)2                                      (3.15) 
𝐶𝐶 = ∑𝑚𝑖𝑚𝑖
�∑𝑚𝑖
2 ∑𝑚𝑖
2
                                                   (3.16) 
 In this, gene expression vectors are denoted by mi and mj. It is always better to define the 
influence of each neighbor based on its distance from the new point. This can be done by 
multiplying class levels by a weighting term. 
In this study, KNN algorithm was applied to all genes in the four microarray datasets and each 
gene’s category was derived using other genes as the training sample. Classification accuracy 
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was confirmed by setting up different k values. Error rate has been calculated by randomly split 
cross validation method. The samples were split from the data available for testing and the rest for 
training dataset. Appendix H shows the R code for all K-NN Procedures. 
 
3.1.11 Obtaining and analyzing the results 
Regularization technique was performed with support vector machine classification for sorting 
out over-fitting issues and enabling accurate feature selection.  Accuracy values of SVM 
classifier, NN and K-NN were compared. The process included training the classifier, calculating 
the confidence levels and testing with an independent database. According to the results obtained 
the best classification model for a microarray data set was obtained. The Chapter 4 discusses the 
detailed results. 
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Chapter 4 
Results and Discussion 
Four different datasets were used to study the classification methods’ performance and to find a 
classifier with the best performance compared to the other classifiers. The SVM classifier was 
trained with the pertinent data; the kernel and the parameters best suited for classification of a 
given microarray data were determined. Different distributions of the dataset for training and test 
datasets were used to ensure what should be positive dataset. The 10-fold cross validation and 
regularization technique was processed to solve the over-fitting issues and feature selection. The 
confusion matrix and the area under curve were calculated. We trained neural network classifiers 
and k- nearest neighbor classifiers with the same datasets.  The following section presents a 
detailed explanation of the results. 
4.1 Colon cancer dataset 
In this section we used the microarray data set of colon cancer to train the classifiers by 
examining each method with suitable parameters. The original dataset consisted of 40 tumor 
samples and 22 normal samples. We evaluated the performance of each classifier by its ability to 
classify to the same number of samples, and then chose the best one. 
4.1.1 Training the SVM with the colon cancer dataset 
As described in the previous chapter, this SVM classifier is a kernel technique. The first step in 
the process is obtaining the test error for linear Kernel and radial kernel to choose the better 
Kernel function with less error.  The test error was 22.7% for the linear kernel and 27.3% for the 
radial kernel. According to the test error result linear kernel was chosen.  The cost of 
misclassification was then chosen and tried with the 10-fold cross validation to return the SVM 
with the best parameters.  Then the best training set was used to predict the class of samples in 
the test set.  The processes were repeated four times with different splits of the dataset for the 
training and test datasets.  The Roc curve and area under curve were calculated to compare the 
classifier performance with different splits for the dataset.  Figures 4.1.a through 4.1.d displays 
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the ROC curve for SVM classifiers for each distribution of the dataset to training dataset and test 
datasets. 
 
Figure 4.1.a: Linear SVM: colon dataset (60:40)  
 
 
 
 
 
 
 
Figure 4.1.b: Linear SVM: colon dataset (70:30) 
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Figure 4.1.c: Linear SVM: colon dataset (80:20) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.d: Linear SVM: colon dataset (90:10) 
For each ROC curve we calculated the area under curve. As shown in Fig. 4.1.a the area under 
curve for the distribution of 60% for training and 40% for test dataset was 0.778. Fig. 4.1.b 
displays the ROC curve for the classifier with 70% training and 30% testing; the area under 
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curve (AUC) was 0.90.  Fig. 4.1.c displays the ROC curve for the classifier with 80% training 
and 20% testing; the AUC was 0.75.  Finally, Fig. 4.1.c displays the ROC curve for the classifier 
with 90% training and 10% testing; the AUC was 0.77. When we compared the AUC between 
the groups of data the distribution of 70% training and 30% testing gave the highest AUC, which 
is 90%. For this result, the split of (70:30) was chosen to complete the process. After that the 
confusion matrix display was used to evaluate the performance of the classifier. The confusion 
matrix shows that two samples out of eleven from the tumor (t) class were misclassified. For the 
normal (n) class one sample out of seven was misclassified. 
         
 
 
 
 
The accuracy for this classifier with colon dataset was 0.833.  
4.1.2 SVM with L1, L2- Regularization for the colon cancer dataset 
When we trained the SVM classifier with colon cancer data the accuracy of the classifier was 
83% with AUC 90%. Then we used L1, L2 regularization with SVM to improve the classifier’s 
performance. We ran the model with 10-fold cross validation, then we re-trained the best model 
with the best-cost value.  Then we used the best model to predict the class of samples in the test 
set.  Figures 4.2.a, 4.2.b displays the ROC curve for SVM with L1 and L2 regularizations. 
 n t total n t 5 2 1 10 6 12 total 7 11 18 
Actual class 
Predicted class 
 46  
 
Figure 4.2.a: Linear SVM with L1 regularization: colon dataset 
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The confusion matrix for SVM with L1, L2 regularization shows three misclassified samples, 
two from tumor class and one from normal class.  
 
 
 
 
 
The accuracy of the classifier didn't change, which remained 83%. But we improved AUC, 
which became 93%. 
 
 n t total n t 6 1 2 9 8 10 total 7 11 18 
Figure 4.2.b: Linear SVM with L2 regularization: colon dataset 
Actual Class 
Predicted class 
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4.1.3 Training Neural Network for colon cancer dataset 
The second classifier we used in this study was the neural network. We trained this method with 
the same pre-processed data. Distribution ranged up to 70% for the training dataset and 30% for 
the test data.  We normalized the value to be predicted and then trained an NN for the training 
data. Finally, we tested the output from the neural network.  Figure 4.3 displays Roc curve of the 
NN for the colon cancer dataset. 
 
 
Figure 4.3: Neural Network: colon dataset 
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We calculated the area under curve (AUC) to evaluate the classifier, which turned out to be 76%. 
The confusion matrix showed that two samples out of eleven from the tumor class were 
misclassified. Two samples out of seven from the normal class were misclassified.  
 
     
 
 
 
 
The accuracy for this classifier with colon dataset was 0.77. 
 
4.1.4 Training K-Nearest Neighbor for colon cancer dataset 
The third classification method we used in this study was KNN. Same pre-processed data were 
used and samples were split into 30% for the test dataset and 70% for the training dataset.  We 
set different k values to choose the best number of neighbors for KNN, which gives the smallest 
test error rates.  We calculated the confusion matrix to evaluate performance of the classifier 
with each k. 
With k=1 the confusion matrix showed that the false positive rate for tumor class three out of 
seven, and the false positive rate for normal class was three out of eleven. For k=2 the false 
positive rate for tumor class was four out of seven, and the false positive rate for normal class 
was two out of eleven. The false positive rate for tumor class with k=3 was four out of seven and 
one out of eleven for the normal class. Finally, with k=4 the false positive rate for tumor class 
was five out of seven, and the false positive rate for normal class was two out of eleven.  Based 
on these outputs, k=3 yields the smallest test error rates. Therefore, we chose k=3 as being the 
best number of neighbors for KNN with this colon dataset. 
    
 n t total n t 5 2 2 9 7 11 total 7 11 18 
Predicted class 
Actual Class 
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The classification result based on k=3 is shown in the ROC curve plot of Figure 4.4. 
 
 
Figure 4.4: K-Nearest Neighbor: colon dataset 
 n t total n t 3 4 1 10 4 14 total 7 11 18 
Predicted class 
Actual Class 
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We calculated the area under curve for this classifier, which was 73%. The accuracy for this 
classifier with the colon dataset was 0.72. 
4.2 Leukemia cancer dataset 
We have used the Leukemia dataset as second group of microarray dataset to examine the 
performance of our three classifiers. Our goal was to determine the confidence level of 
classifying two types of leukemia known as ALL and AML. The original dataset consists of 48 
ALL samples and 25 AML samples. We trained the three classifiers with this pre-classified data 
and, according to the test error, the best classification method was determined. 
4.2.1 Training the SVM with Leukemia cancer dataset 
We trained linear kernel SVM to classify the leukemia dataset.  The cost of misclassification was 
chosen and tried with 10-fold cross validation to return the SVM with best parameters. Then the 
best model of training set was used to predict the class of samples in the test set. We repeated the 
process four times with different splits of the dataset for training and test dataset.  ROC curve 
and area under curve were calculated to compare the classifier performance with different split 
for the dataset.  Figures 4.5.a, 4.5.b, 4.5.c, and 4.5.d display ROC curve for SVM classifier for 
each distribution of the training dataset and test dataset.  
Figure 4.5.a: Linear SVM: Leukemia dataset (60:40) 
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Figure 4.5.b: Linear SVM: Leukemia dataset (70:30)  
 
Figure 4.5.c: Linear SVM: Leukemia dataset (80:20)  
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Figure 4.5.d: Linear SVM: Leukemia dataset (90:10)  
For each ROC curve we calculated the area under curve. As shown in Figures 4.5.a, 4.5.b, 4.5.c, 
4.5.d the area under curves for all distribution of the data for training and testing was 100%. This 
result shows that these datasets were made in good frames, changing partitions does not affect 
the classification result. We have chosen the split of (70:30) to complete the process. Confusion 
matrix was used to evaluate performance of the classifier. The confusion matrix shows that one 
sample out of fourteen from the AML class was misclassified. For the ALL class none were 
misclassified.  
 
            
 
 
 
The accuracy for this classifier with leukemia dataset was 0.97 with AUC 100%. The SVM 
classifier performed well with this group of data and gives a high accuracy. According to this 
 ALL AML total ALL AML 20 0 1 13 21 13 total 20 14 24 
Predicted class 
Actual Class 
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result we did not need the regularization technique to improve the classifier performance with 
leukemia data. 
4.2.2 Training Neural Network for leukemia cancer dataset 
We trained neural network classifier with leukemia dataset. After doing the pre-process step the 
distribution of the data was 70% for training and 30% for testing. We normalized the values to be 
predicted and trained the NN for the training data. ROC curve shown in Figure 4.6 was used to 
evaluate the performance of NN for leukemia cancer dataset. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.6: Neural Network: Leukemia dataset  
 55  
We calculated the area under curve for this classifier, which was AUC 86%. The confusion 
matrix shows that one sample out of twenty samples from the ALL class was misclassified.  Four 
samples out of fourteen samples from the AML class were misclassified. 
 
            
 
 
 
 
The accuracy for this classifier with leukemia dataset was 0.85. 
4.2.3 Training K-Nearest Neighbor for leukemia cancer dataset 
We trained K-Nearest Neighbor classifier with the leukemia dataset. The same pre-processed 
data were used and samples were split into 30% for test dataset and 70% for the training dataset. 
We set different k values to choose the best number of neighbors for KNN, which gives the 
smallest test error rates.  We calculated the confusion matrix to evaluate performance of the 
classifier with each k. 
With k=1 the confusion matrix shows that the false positive rate for ALL class was zero out of 
twenty, and the false positive rate for AML class was three out of fourteen. For k=2 the false 
positive rate for ALL class was one out of twenty, and the false positive rate for AML class was 
two out of fourteen. The false positive rate for ALL class with k=3 was zero out of twenty and 
four out of fourteen for the AML class. Finally, with k=4 the false positive rate for ALL class 
was zero out of twenty, and the false positive rate for AML class was four out of fourteen.  
Based on these outputs, k=1 yields the smallest test error rates. Therefore, we chose k=1 as the 
best number of neighbors for KNN with this leukemia dataset. 
 
                
 ALL AML total ALL AML 19 1 4 10 23 11 total 20 14 24 
Predicted class 
Actual Class 
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The classification result based on k=1 is shown in the ROC curve plot of Figure 4.7. 
 
 
Figure 4.7: K-Nearest Neighbor: Leukemia dataset  
 
 ALL AML total ALL AML 20 0 3 11 23 11 total 20 14 24 
Predicted class 
Actual Class 
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We calculated the area under curve for this classifier, which was 93%. The accuracy for this 
classifier with the leukemia dataset was 0.91.  
4.3 Breast cancer dataset 
We have used a breast cancer dataset to examine the performance of three classification 
methods. With the breast cancer dataset we tried to determine the confidence level of classifying 
two groups of breast cancer patients; 34 samples from patients who developed distant metastases 
(DM) within 5 years and 44 samples from patients who continue to be disease-free (NODM) 
after a period of at least 5 years. We trained the three classifiers with this pre-classified data and 
the best classification method was determined. 
 
4.3.1 Training the SVM with Breast cancer dataset 
We trained linear kernel SVM to classify the breast cancer dataset. The cost of misclassification 
was chosen and tried with 10-fold cross validation to return the SVM with best parameters. Then 
the best model of training set was used to predict the class of samples in the test set.  We 
repeated the process four times with different splits for the dataset to train and test the dataset.  
ROC curve and area under curve were calculated to compare the classifier performance with 
different split for the dataset. Figures 4.8.a, 4.8.b, 4.8.c, 4.8.d display ROC curve for SVM 
classifier for each distribution of the dataset to train dataset and test dataset. 
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Figure 4.8.a: Linear SVM: breast dataset (60:40) 
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Figure 4.8.b: Linear SVM: breast dataset (70:30) 
 
Figure 4.8.c: Linear SVM: breast dataset (80:20) 
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Figure 4.8.d: Linear SVM: breast dataset (90:10)  
For each ROC curve we calculated the area under the curve. As shown in Fig. 4.8.a, the area 
under the curve for the distribution of 60% for training and 40% for test dataset was 0.72. Fig. 
4.1.b displays the ROC curve for the classifier with 70% training and 30% testing and the AUC 
was 0. 67.  Fig. 4.1.c displays the ROC curve for the classifier with 80% training and 20% 
testing and the AUC was 0.61. Finally Fig. 4.1.d displays the ROC curve for the classifier with 
90% training and 10% testing and the AUC was 0.41. When we compared the AUC between the 
groups of data, the distribution of 60% training and 40% testing gave the highest AUC, which 
was 72%. For this result the split of (60:40) was chosen to complete the process. After that we 
used the confusion matrix to evaluate performance of the classifier. The confusion matrix shows 
that six samples out of ten from the DM class were misclassified. For the NODM class two 
samples out of thirteen were misclassified.  
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The accuracy for this classifier with breast cancer dataset was 0.65. 
 
4.3.2 SVM with L1, L2- Regularization for breast cancer dataset 
We used L1, L2 regularization with SVM to improve the classifier performance with the breast 
dataset. We ran the model with 10-fold cross validation, and then we re-trained the best model 
with best-cost value.  The best model was used to predict the class of samples in the test set. 
Figures 4.9.a and 4.9.b display ROC curve for SVM with L1 and L2 regularization. 
 DM NODM total DM NODM 4 6 2 11 6 17 total 10 13 23 
Predicted class 
Actual Class 
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Figure 4.9.a: Linear SVM with L1 regularization: breast dataset 
The confusion matrix for SVM with L1 regularization showed seven misclassified samples; six 
were from the DM class and one came from the NODM class. 
 
             
 
 
 
  The accuracy of the classifier was 69%, with AUC 74%. 
 DM NODM total DM NODM 4 6 1 12 5 17 total 10 13 23 
Predicted class 
Actual Class 
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Figure 4.9.b: Linear SVM with L2 regularization: breast dataset 
The confusion matrix for SVM with L2 regularization showed seven misclassified samples; five 
were from DM class and one came from NODM class.  
 
 
 
 
  The accuracy of the classifier is 73%, with AUC 72%. 
 DM NODM total DM NODM 5 5 1 12 5 17 total 10 13 23 
Predicted class 
Actual Class 
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4.3.3 Training Neural Network for breast cancer dataset 
We trained the neural network classifier with the breast cancer dataset. After doing the pre-
processing steps, the distribution of the data for 60% training and 40% testing was used. We 
normalized the values to be predicted and then trained a NN for the training data. ROC curve 
shown in Figure 4.10 was used to evaluate the performance of NN for the breast cancer dataset. 
 
Figure 4.10: Neural Network: breast dataset 
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We calculated the area under curve (AUC) to evaluate the classifier, which was 55%.  The 
confusion matrix showed that five samples out of ten from the DM class were misclassified. Five 
samples out of thirteen from NODM class were misclassified. 
 
 
 
 
The accuracy for this classifier with colon dataset was 0.56. 
 
4.3.4 Training K-Nearest Neighbor for breast cancer dataset 
We trained K-Nearest Neighbor classifier for breast cancer dataset.  Same pre-processed data 
were used and samples were split into 40% for test dataset and 60% for training dataset.  We set 
different k values to choose the best number of neighbors for KNN, which gives the smallest test 
error rates.  We calculated the confusion matrix to evaluate performance of the classifier with 
each k value. 
With k=1 the confusion matrix shows that the false positive rate for DM class was nine out of 
ten, and the false positive rate for NODM class was five out of thirteen. For k=2 the false 
positive rate for DM class was eight out of ten, and the false positive rate for NODM class was 
five out of thirteen. The false positive rate for DM class with k=3 was eight out of ten and four 
out of thirteen for the NODM class. Finally, with k=4 the false positive rate was the same as k=3.  
Based on these outputs, k=3 yields the smallest test error rates. Therefore, we chose k=3 as the 
best number of neighbors for KNN with this breast cancer dataset. 
 
         
 DM NODM total DM NODM 5 5 5 8 10 13 total 10 13 23 
Predicted class 
Actual Class 
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Classification result based on k=3 is shown in the ROC curve plot of Figure 4.11. 
 
Figure 4.11: K-Nearest Neighbor: breast dataset  
We calculated the area under curve (AUC) for this classifier, which was 43%. The accuracy for 
this classifier with the breast cancer dataset was 0.47. 
 DM NODM total DM NODM 2 8 4 10 6 18 total 10 14 24 
Predicted class 
Actual Class 
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4.4 Prostate cancer dataset 
We have also used a prostate cancer dataset to examine the performance of the three 
classification methods. With the prostate cancer dataset we tried to determine the confidence 
level of classifying two groups of prostate cancer patients and healthy men. There were 52 
prostate cancer patients and 50 healthy men. We trained the three classifiers with this pre-
classified data and the best classification method was determined. 
4.4.1 Training the SVM with Prostate cancer dataset 
We trained linear kernel SVM to classify prostate cancer datasets. The cost of misclassification 
was chosen and tried with 10-fold cross validation to return the SVM with best parameters. Then 
the best model of training set was used to predict the class of samples in the test set. We repeated 
the process four times with different splits for the dataset to train and test dataset.  ROC curve 
and area under curve were calculated to compare the classifier performance with different splits 
for the dataset. Figures 4.12.a, through 4.12.d display ROC curve for SVM classifier for each 
distribution of the dataset to train and test dataset. 
 
Figure 4.12.a: Linear SVM: prostate dataset (60:40)  
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Figure 4.12.b: Linear SVM: prostate dataset (70:30)  
 
Figure 4.12.c: Linear SVM: prostate dataset (80:20) 
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Figure 4.12.d: Linear SVM: prostate dataset (90:10) 
For each ROC curve we calculated the area under the curve. As shown in Fig. 4.12.a, the area 
under the curve (AUC) for the distribution of 60% for training and 40% for test dataset was 0.70. 
Fig. 4.12.b displays the ROC curve for the classifier with 70% training and 30% testing and the 
AUC was 0.78.  Fig. 4.12.c displays the ROC curve for the classifier with 80% training and 20% 
testing and the AUC was 0.76.  Finally, Fig. 4.12.d displays the ROC curve for the classifier with 
90% training and 10% testing and the AUC was 0.75. When we compared the AUC between the 
groups of data, the distribution of 70% training and 30% testing gave the highest AUC, which 
was 78%. For this result the split of (70:30) was chosen to complete the process. After that, we 
used the confusion matrix to evaluate performance of the classifier. The confusion matrix shows 
that seven samples out of eighteen from the cancer class were misclassified. For the healthy class 
two samples out of twelve were misclassified.  
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The accuracy for this classifier with the prostrate dataset was 0.76. 
 
4.4.2 SVM with L1, L2- Regularization for prostate cancer dataset 
When we trained SVM classifier with prostate cancer data the accuracy of the classifier was 76% 
with AUC 78%. Then we used L1, L2 regularization with SVM to improve the classifier’s 
performance.  We ran the model with 10-fold cross validation, then we re-trained best model 
with best-cost value. The best model was used to predict the class of samples in the test set.  
Figures 4.13.a and 4.13.b displays ROC curve for SVM with L1 and L2 regularization. 
 Cancer healthy total 
Cancer  
healthy 11 7 2 10 13 17 total 18 12 30 
Predicted class 
Actual Class 
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Figure 4.13.a: Linear SVM with L1 regularization: prostate dataset 
 
The confusion matrix for SVM with L1 regularization showed six misclassified samples, four 
from the cancer class and two from the healthy class.  
             
 
 
 
The accuracy of the classifier was 80%, with AUC 88%. 
 Cancer healthy total 
Cancer  
healthy 14 4 2 10 16 14 total 18 12 30 
Predicted class 
Actual Class 
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Figure 4.13.b: Linear SVM with L2 regularization: prostate dataset 
The confusion matrix for SVM with L2 regularization showed seven misclassified samples; five 
were from the cancer class and two came from the healthy class. 
 
 
 
 
 
The accuracy of the classifier was 76%, with AUC 77% 
 Cancer healthy total 
Cancer  
healthy 13 5 2 10 13 17 total 18 12 30 
Actual Class 
Predicted class 
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4.4.3 Training Neural Network for prostate cancer dataset 
We trained neural network classifier with prostate dataset. After doing the pre-processing step, 
the distribution of the data came to 70% training and 30% testing. We normalized the value to be 
predicted and trained the NN for the training data. ROC curve displayed in Figure 4.14 was used 
to evaluate the performance of NN for pro prostate cancer dataset. 
 
Figure 4.14: Neural Network: prostate dataset 
We calculated the area under the curve (AUC) to evaluate the classifier, which was 77%. The 
confusion matrix shows that six samples out of eighteen from the cancer class were 
misclassified. One sample out of twelve from healthy class was misclassified. 
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The accuracy for this classifier with prostrate dataset was 0.75. 
4.3.4 Training K-Nearest Neighbor for prostate cancer dataset 
We trained K-Nearest Neighbor classifier with prostate dataset.  Same pre-processed data were 
used and samples were split into 30% for test dataset and 70% for training dataset.  We set 
different k values to choose the best number of neighbors for KNN, which gives the smallest test 
error rates.  We calculated the confusion matrix to evaluate performance of the classifier with 
each k. 
With k=1 the confusion matrix shows that the false positive rate for the cancer class was six out 
of eighteen, and the false positive rate for the healthy class was five out of twelve. For k=2 the 
false positive rate for cancer class was six out of eighteen, and the false positive rate for the 
healthy class was seven out of twelve. The false positive rate for the cancer class with k=3 was 
three out of eighteen and eight out of twelve for the healthy class. Finally, with k=4 the false 
positive rate was three out of eighteen for the cancer class, and seven out of twelve for the 
healthy class.  Based on these outputs, k = 4 yielded the smallest test error rates. Therefore, we 
chose k = 4 as the best number of neighbors for KNN with this prostate cancer dataset. 
     
 
 
 
The classification result based on k=4 is shown in the ROC curve plot of Figure 4.15. 
 Cancer healthy total 
Cancer  
healthy 12 6 1 11 13 17 total 18 14 30 
 Cancer healthy total 
Cancer  
healthy 10 7 3 10 13 17 total 17 13 30 
Predicted class 
Actual Class 
Predicted class 
Actual Class 
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Figure 4.15: K-Nearest Neighbor: prostate dataset   
We calculated the area under curve for this classifier, which was 65%. The accuracy for this 
classifier with the prostate cancer dataset was 0.66.  
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4.2 Discussion 
The results presented in this chapter clearly suggest that the SVM gives accurate results with 
high accuracies and the number of misclassifications drastically lowers when SVM classification 
was performed with the L1 and L2 regularization. 
4.2.1 Evaluating the classifiers Performance 
The classifiers were evaluated by comparing the accuracies of each classifier. Table 4.1 
compares the confusion matrices (error rates) of each classifier and the area under curve for the 
colon dataset. 
 
Table4.1: Comparison of classification accuracies for colon dataset 
 
 
Methods 
 
Confusion matrix Accuracy 
 
 
 
Area under 
curve 
 
FP 
 
FN 
 
TP 
 
TN  SVM  1  2  5  10  83  90 
SVM-L1  
2 
 
1 
 
6 
 
9 
 
83 
 
93 
SVM-L2  
2 
 
1 
 
6 
 
9 
 
83 
 
93  NN  2  2  5  9  77  76  KNN 1 4 3 10 72 73  
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The methods are linear kernel basis function SVM, neural network and k nearest neighbor.  The 
six columns are the false positive, false negative, true positive, true negative, followed by 
accuracy and area under curve. 
Table 4.2 compares the confusion matrices (error rates) of each classifier and the area under 
curve for the leukemia dataset. 
 
Table4.2: Comparison of classification accuracies for leukemia dataset 
  
Methods 
 
Confusion matrix Accuracy 
 
 
 
Area under 
curve 
 
FP 
 
FN 
 
TP 
 
TN  SVM  1  0  20  13  97  100  NN  4  1  19  10  85  86  KNN 3 0 20 11 91 93 
 
Similarly, table 4.3 compares the confusion matrices (error rates) of each classifier and the area 
under curve for the breast dataset. 
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Table4.3: Comparison of classification accuracies for breast dataset 
 
 
Methods 
 
Confusion matrix Accuracy 
 
 
 
Area under 
curve 
 
FP 
 
FN 
 
TP 
 
TN  SVM  2  6  4  11  65  72 
SVM-L1  
1 
 
6 
 
4 
 
12 
 
69 
 
74 
SVM-L2  
1 
 
5 
 
5 
 
12 
 
73 
 
74  NN  5  5  5  8  56  55  KNN 4 8 2 10 47 43 
 
Table 4.4 compares the confusion matrices (error rates) of each classifier and the area under 
curve for the prostate dataset. 
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Table4.4: Comparison of classification accuracies for prostate dataset 
 
 
Methods 
 
Confusion matrix Accuracy 
 
 
 
Area under 
curve 
 
FP 
 
FN 
 
TP 
 
TN  SVM  2  7  11  10  76  78 
SVM-L1  
2 
 
4 
 
14 
 
10 
 
80 
 
88 
SVM-L2  
2 
 
5 
 
13 
 
10 
 
76 
 
77  NN  1  6  12  11  75  77  KNN 7 3 15 5 66 65   
Tables 4.1, 4.2, 4.3 and 4.4 suggest that in most of the cases, the SVM performs better than NN 
and KNN and the uses of L1 and L2 with SVM did improve SVM performance. Through in 
some datasets we had accuracy of SVM classifier equivalent to SVM-L1 and SVM-L2, but this 
improved in area under curve with SVM-L1 and SVM-L2 (refer to table 4.1).  Also, in some 
datasets we had accuracy of SVM classifier better than SVM-L2 (refer to table 4.4).  Some 
datasets had a high accuracy of SVM classifier, so there was no need to use regularization 
technique.  Confusion matrix showed the error rates of the classification, and in all cases SVM 
had a small number (false positive rate) of misclassified samples.  Table 4.5 shows the 
accuracies of the classifiers for all the datasets obtained from the Table 4.1 through 4.4. It clearly 
suggests that the SVM outperforms all the classifiers consistently. 
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Table4.5: Comparison of classification accuracies for all dataset 
Dataset 
SVM 
NN KNN SVM SVM-L1 SVM-L2 
Colon 
83 83 83 77 72 
Leukemia 97 - - 85 91 
Breast 
65 69 73 56 47 
Prostate 76 80 76 75 66 
 
For every dataset the best performing method is a support vector machine using the linear kernel 
basis. In three separate tests, the linear basis SVM performs better than neural network and k-
nearest neighbor.    
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Chapter 5 
Conclusions 
The aim of the present study was to determine the confidence level in classifying an unknown 
gene sample, based on the microarray data using SVM and two other classifiers, NN and KNN.  
The classifiers were evaluated and had their performances compared with each other.  SVM had 
outperformed the other classifiers consistently. 
Two types of kernel techniques were used and compared. Linear Kernel was chosen according to 
the test error rate. The analysis of linear Kernel SVM was performed using different percentages 
of distribution of the dataset for training and testing datasets. We received the best result for 
colon-cancer data, with distribution of 70% training and 30% testing. For leukemia dataset, 
changing the data distribution did not affect the result which we had chosen for the split of 70:30, 
to complete the process. The distribution of 60% training and 40% testing was chosen for breast-
cancer dataset which gave best results. Finally, the distribution of 70% training and 30% testing 
was chosen to complete the process with prostate dataset. 
The cost of misclassification was chosen and tried with the 10-fold cross validation (LOOCV 
method) to return the SVM with best parameters. Then, the best training model set was used to 
predict the class of samples in the test set. 
The L1 L2 regularization techniques were processed to solve the over-fitting issues and feature 
selection in classification.  A confusion matrix and ROC curve was used to evaluate the 
classifier’s performance. 
The neural network was the second classifier that was used in this study and was compared with 
SVM classifier. The same distribution of the datasets split for SVM was used with NN.  We 
normalized the value to be predicted and then trained NN for the training data.  Area under the 
curve and the confusion matrix was calculated to evaluate the classifier. 
The third classification method used in this study was KNN. Same distribution of the datasets 
split with other classifiers was used.   Different k values were set to choose the best number of 
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neighbors for KNN, which gives the smallest test error rates. Confusion matrix was calculated to 
evaluate the performance of the classifier, with each k and the chosen k with the best number of 
neighbors. 
The classifiers were evaluated by comparing the accuracies of each classifier. Confusion matrix 
showed the error rates of the classification, and in all cases, SVM had a small number (false 
positive rate) of misclassified samples.  The highest accuracy of colon data was 83% with SVM 
classifier, while the accuracy of NN with the same data was 77% and KNN was 72%.  Leukemia 
data had the highest accuracy of 97% with SVM, 85% with NN, and 91% with KNN. For breast 
data, the highest accuracy was 73% with SVM-L2, while the accuracy was 56% with NN and 
47% with KNN.  Finally, the highest accuracy of prostate data was 80% with SVM-L1, while the 
accuracy was 75% with NN and 66% with KNN. 
To conclude, the results in this study clearly suggested that SVM performs better than NN and 
KNN. SVM gives accurate results with high accuracies, and the number of misclassifications 
drastically lowers when SVM classification was performed with the L1 and L2 regularization. 
Future work 
The results of the current study give us a clear picture of the stability of SVM classifier approach 
for the classification of a microarray dataset. SVM classifier approach can be applied to several 
other datasets for classification purposes and the stability of the method analyzed. Results 
attained in a classification problem are very much dependent on the preprocessing method used 
for the dataset. It might be possible to increase the stability of the classification model by trying 
different data preprocessing techniques. We can also apply other techniques to improve the 
accuracy of SVM like particle swarm optimization (PSO) and then do a comparative study with 
the SVM-L1, SVM-L2. Applying the above variations we can get more results and hence 
analyze the variations in the classification of samples. The work can be extended with the 
addition of new classifier methods such as Bayesian etc. for increasing the classification power 
on newly generated dataset. 
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APPENDIX A 
GENERATING TRAINING AND TEST DATA RANDOMLY 
## Colon-cancer dataset with different split for the data (60:40; 70:30; 80:20; 90:10) 
rm(list=ls()) 
library(LiblineaR) 
library(caret) 
library(class) 
library(e1071) 
library(ROCR) 
library(Biobase) 
library(genefilter) 
library(colonCA) 
# set path and load helper functions 
proj_path = file.path(Sys.getenv("HOME"), "Projects/71_makke/phase2") 
source(file.path(proj_path, "helper.R")) 
# load data 
data(colonCA) 
# split into training and testing subsets 
train.pct = c(0.6, 0.7, 0.8, 0.9) 
for (pct in train.pct) { 
 # get training and testing set for each pct 
lst = mk_train_test_df(colonCA, pct.train=pct, yvar="class")     
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   # fit linear kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=lst$df.train, kernel="linear",  
decision.values=TRUE,  
                        ranges = list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100)))      
        # choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
        # use the best model to predict on test set 
ypred = predict(bestmod, lst$df.test, decision.values=TRUE) 
   # plot ROC Curve and calculate AUC 
        fitted = attributes(ypred)$decision.values 
auc = rocplot(fitted, lst$df.test$y,  
                      main=paste0("Linear SVM on ColonCA Test Data: ",  
pct*100, ":", (1-pct)*100))  
        cat("Area Under the Curve: ", auc) 
} 
## Leukemia dataset with different split for the data (60:40; 70:30; 80:20; 90:10) 
rm(list=ls()) 
library(LiblineaR) 
library(caret) 
library(class) 
library(e1071) 
library(Biobase) 
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library(genefilter) 
library(ROCR) 
library(golubEsets) 
if (!require(a4Base)) { 
        source("http://bioconductor.org/biocLite.R") 
biocLite("a4Base") 
} else {library(a4Base)} 
# set path and load helper functions 
proj_path = file.path(Sys.getenv("HOME"), "Projects/71_makke/phase2") 
source(file.path(proj_path, "helper.R")) 
# load data 
data(Golub_Train) 
data(Golub_Test) 
Golub = combineTwoExpressionSet(Golub_Train, Golub_Test) 
# dim(Golub) == dim(Golub_Train) + dim(Golub_Test) 
# split into training and testing subsets 
train.pct = c(0.6, 0.7, 0.8, 0.9) 
for (pct in train.pct) { 
        # get training and testing set for each pct 
lst = mk_train_test_df(Golub, pct.train=pct, yvar="ALL.AML") 
        # fit linear kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=lst$df.train, kernel="linear",  
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decision.values=TRUE,  
                        ranges = list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100))) 
 
        # choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
        # use the best model to predict on test set 
ypred = predict(bestmod, lst$df.test, decision.values=TRUE) 
# plot ROC Curve and calculate AUC 
        fitted = -attributes(ypred)$decision.values 
auc = rocplot(fitted, lst$df.test$y,  
                      main=paste0("Linear SVM on Golub Test Data: ",  
pct*100, ":", (1-pct)*100))  
        cat("Area Under the Curve: ", auc) 
} 
## Breast-cancer dataset with different split for the data (60:40; 70:30; 80:20; 90:10) 
rm(list=ls()) 
library(LiblineaR) 
library(caret) 
library(class) 
library(e1071) 
library(Biobase) 
library(genefilter) 
library(ROCR) 
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library(cancerdata) 
# set path and load helper functions 
proj_path = file.path(Sys.getenv("HOME"), "Projects/71_makke/phase2") 
source(file.path(proj_path, "helper.R")) 
# load data 
data(VEER1) 
# split into training and testing subsets 
train.pct = c(0.6, 0.7, 0.8, 0.9) 
for (pct in train.pct) { 
        # get training and testing set for each pct 
lst = mk_train_test_veer1(VEER1, pct.train=pct, yvar="class") 
  # fit linear kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=lst$df.train, kernel="linear",  
decision.values=TRUE, 
                        ranges=list(cost=c(0.00001, 0.001, 0.005, 0.01, 0.05,  
                                           0.1, 0.2, 0.5, 1, 5, 10))) 
# choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
        # use the best model to predict on test set 
ypred = predict(bestmod, lst$df.test, decision.values=TRUE) 
 
        # plot ROC Curve and calculate AUC 
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        fitted = attributes(ypred)$decision.values 
auc = rocplot(fitted, lst$df.test$y,  
                      main=paste0("Linear SVM on VEER1 Test Data: ",  
pct*100, ":", (1-pct)*100))  
        cat("Area Under the Curve: ", auc) 
} 
## Prostate-cancer dataset with different split for the data (60:40; 70:30; 80:20; 90:10) 
rm(list=ls()) 
library(LiblineaR) 
library(caret) 
library(class) 
library(e1071)   
library(genefilter) 
library(ROCR) 
library(Biobase) 
library(sda) 
# set path and load helper functions 
proj_path = file.path(Sys.getenv("HOME"), "Projects/71_makke/phase2") 
source(file.path(proj_path, "helper.R")) 
# load data 
data(singh2002) 
X = singh2002$x  
y = singh2002$y 
 94  
train.pct = c(0.6, 0.7, 0.8, 0.9) 
for (pct in train.pct) { 
        # get training and testing set for each pct 
lst = mk_train_test_prostate(X, y, pct) 
   # fit linear kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=lst$df.train, kernel="linear",  
decision.values=TRUE,  
                        ranges = list(c(0.00001, 0.001, 0.005, 0.01, 0.05, 0.1,  
                                        0.2, 0.5, 1, 5, 10))) 
 
     # choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
    # use the best model to predict on test set 
ypred = predict(bestmod, lst$df.test, decision.values=TRUE) 
   # plot ROC Curve and calculate AUC 
        fitted = attributes(ypred)$decision.values 
auc = rocplot(fitted, lst$df.test$y,  
                      main=paste0("Linear SVM on Prostate Test Data: ",  
pct*100, ":", (1-pct)*100))  
        cat("Area Under the Curve: ", auc) 
} 
####################################################### 
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## “ helper.R” 
## BEGIN Defining Functions 
mmfilt = function(r=5, d=500, na.rm=TRUE) { 
function(x) { 
minval = min(x, na.rm=na.rm) 
maxval = max(x, na.rm=na.rm) 
                (maxval/minval>r) && (maxval-minval>d) 
        }} 
mmfun = mmfilt() 
ffun = filterfun(mmfun) 
get_sub = function(eset, f) { 
Wlow = 100 
Whigh = 16000 
x = exprs(eset) 
x[x<Wlow] = Wlow 
x[x>Whigh] = Whigh 
genefilter(x, f) 
} 
rocplot = function(pred, truth, ...) { 
predob = prediction(pred, truth) 
perf = performance(predob, "tpr", "fpr") 
        plot(perf, ...) 
# return AUC 
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auc.tmp = performance(predob, "auc") 
auc = as.numeric(auc.tmp@y.values) 
} 
svm.regularization = function(X.train, y.train) { 
function(type, folds=10) { 
tryCosts = c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100) 
bestCost = NA 
bestAcc = 0 
for (cointryCosts) { 
acc = LiblineaR(data=X.train, labels=y.train, type=type,  
cost=co, bias=TRUE, cross=folds,  
verbose=FALSE) 
cat("Results for C=", co, " : ", acc, " accuracy.\n",  
sep="") 
if(acc>bestAcc){ 
bestCost=co 
bestAcc=acc}   } 
                cat("Best cost is:", bestCost, "\n") 
                cat("Best accuracy is:", bestAcc, "\n") 
                c(bestCost=bestCost) 
        }        } 
idx.train = function(df, pct.train=0.6) { 
n = ncol(df) 
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size_train = ceiling(n * pct.train) 
set.seed(10384) 
        sample(1:n, size_train) 
} 
mk_train_test_df = function(dat, pct.train=0.6, yvar) { 
train = idx.train(dat, pct.train) 
dat_train = dat[, train] 
dat_test  = dat[, -train]  
# filter out genes 
sub = get_sub(dat, ffun) 
# subset the training and testing data using the filtered-out genes 
dat_trainSub = dat_train[sub, ] 
dat_testSub = dat_test[sub, ] 
# transform training and test sets to data.frame 
X.train = t(exprs(dat_trainSub)) 
X.test  = t(exprs(dat_testSub)) 
# make training data frame 
X.train = scale(X.train, center=TRUE, scale=TRUE) # scale X.train 
y.train = factor(dat_trainSub[[yvar]]) 
df.train = data.frame(X.train, y=y.train) 
# make testing data frame 
X.test = scale(X.test, attr(X.train, "scaled:center"),  
attr(X.train, "scaled:scale")) # scale X.test 
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y.test = factor(dat_testSub[[yvar]]) 
df.test = data.frame(X.test, y=y.test)         
list(df.train=df.train, df.test=df.test)} 
idx_col_w_NA= function(df) { 
idx = c() 
for (iin1:ncol(df)) 
if (sum(is.na(df[, i])) >0) idx = c(idx, i) 
idx} 
mk_train_test_prostate = function(X, y, pct.train=0.6) {         
# split into training and testing subsets 
n = length(y) 
size_train = ceiling(n * pct.train) 
set.seed(10384) 
train = sample(1:n, size_train) 
X.train = X[train, ]; y.train = y[train] 
X.test  = X[-train, ]; y.test = y[-train]   
# make training data frame 
X.train = scale(X.train, center=TRUE, scale=TRUE) # scale X.train 
df.train = data.frame(X.train, y = y.train) 
# make testing data frame 
X.test = scale(X.test, attr(X.train, "scaled:center"),  
attr(X.train, "scaled:scale")) # scale X.test 
df.test = data.frame(X.test, y = y.test) 
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list(df.train=df.train, df.test=df.test)        } 
mk_train_test_veer1 = function(dat, pct.train=0.6, yvar) { 
train = idx.train(dat, pct.train) 
dat_train = dat[, train] 
dat_test  = dat[, -train]  
# transform training and test sets to data.frame 
X.train = t(exprs(dat_train)) 
X.test  = t(exprs(dat_test)) 
delete.col.idx = c(idx_col_w_NA(X.train), idx_col_w_NA(X.test))  
# make training data frame 
X.train = X.train[, -delete.col.idx] 
X.train = scale(X.train, center=TRUE, scale=TRUE) # scale X.train 
y.train = factor(dat_train[[yvar]]) 
df.train = data.frame(X.train, y=y.train) 
# make testing data frame 
X.test = X.test[, -delete.col.idx] 
X.test = scale(X.test, attr(X.train, "scaled:center"),  
attr(X.train, "scaled:scale")) # scale X.test 
y.test = factor(dat_test[[yvar]]) 
df.test = data.frame(X.test, y=y.test)         
list(df.train=df.train, df.test=df.test) 
} 
## END Defining Functions  
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APPENDIX B 
Preprocessing, transformations and filter the data 
## BEGIN Defining Functions 
mmfilt = function(r=5, d=500, na.rm=TRUE) { 
function(x) { ## Filter methods select     
## features according to          
                      ## criteria that are  
                      ## independent of those  
                      ## criteria that the classifier  
                      ## optimizes. 
minval = min(x, na.rm=na.rm) 
maxval = max(x, na.rm=na.rm) 
           (maxval/minval>r) && (maxval-minval>d) 
        } 
} 
mmfun = mmfilt() 
ffun = filterfun(mmfun) 
## Windsorizing the data (setting the minimum expression  ## values to 100 and the maximum to 
16000) 
get_sub = function(eset, f) { 
Wlow = 100 
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Whigh = 16000 
x = exprs(eset) 
x[x<Wlow] = Wlow 
x[x>Whigh] = Whigh 
genefilter(x, f)} 
# filter out genes (Leukemia dataset) 
sub = get_sub(Golub_Train, ffun) 
sum(sub) 
# filter out genes (Colon cancer dataset) 
sub = get_sub(colonCA, ffun) 
sum(sub) _________________________________________________________________________________________________________ 
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APPENDIX C 
Training SVM classifier with Liner Kernel and Redial Kernel 
# # radial kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=df.train, kernel="radial",  
ranges=list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 10, 100),  
              gamma=c(0.0001, 0.001, 0.01, 0.1, 
           0.5, 1))) 
summary(tune.out) 
 
# # choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
 summary(bestmod) 
# # use the best model to predict on test set 
ypred = predict(bestmod, df.test) 
 table(predict=ypred, truth=df.test$y) 
# linear kernel svm on training set with 10-fold CV 
set.seed(100) 
tune.out = tune(svm, y~., data=df.train, kernel="linear", decision.values=TRUE, 
ranges = list(cost=c(0.001, 0.01, 0.05, 0.1, 1, 5, 10, 100))) 
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summary(tune.out) 
# choose the best model from 10-fold CV 
bestmod = tune.out$best.model 
summary(bestmod) 
# use the best model to predict on test set 
ypred = predict(bestmod, df.test, decision.values=TRUE) 
( tbl = table(predict=ypred, truth=df.test$y) ) 
( test.error = (tbl[1,2] + tbl[2,1]) / sum(tbl) ) 
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APPENDIX D 
Display confusion Matrix 
#input 
library(caret)  
lvs<- c("AML", "ALL") 
truth<- factor(rep(lvs, times = c(14, 20)), 
levels = rev(lvs)) 
pred<- factor( 
                 c( 
                   rep(lvs, times = c(13, 1)), 
                   rep(lvs, times = c(0, 20))),                
levels = rev(lvs)) 
xtab<- table(pred, truth) 
confusionMatrix(xtab) 
______________________________________________________________________________ 
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APPENDIX E 
Plot  ROC Curve and  calculate Area Under Curve  
rocplot = function(pred, truth, ...) { 
predob = prediction(pred, truth) 
perf = performance(predob, "tpr", "fpr") 
        plot(perf, ...) 
# return AUC 
auc.tmp = performance(predob, "auc") 
auc = as.numeric(auc.tmp@y.values) 
# plot ROC Curve and calculate AUC 
fitted = attributes(ypred)$decision.values 
( auc = rocplot(fitted, df.test$y, main="Linear SVM: ColonCA Test Data") ) 
______________________________________________________________________________ 
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APPENDIX F 
SVM with L1 regularization  
# svm with L1 regularization with 10-fold CV 
set.seed(100) 
t = 3 
svm.L1 = svm.regularization(X.train, y.train) 
bestCost = svm.L1(type=t, folds=10) 
# re-train best model with best cost value 
bestmod = LiblineaR(data=X.train, labels=y.train, type=t, cost=bestCost,  
bias=TRUE, verbose=FALSE) 
# make prediction 
ypred = predict(bestmod, X.test, proba=FALSE, decisionValues=TRUE) 
# Display confusion matrix 
( tbl = table(predict=ypred$predictions, truth=df.test$y) ) 
confusionMatrix(tbl) 
fitted = ypred$decisionValues[,1] 
( auc = rocplot(fitted, df.test$y,  
main="Linear SVM with L1 regularization: ColonCA Test Data") ) 
 
SVM with L2 regularization 
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# svm with L2 regularization with 10-fold CV 
set.seed(100) 
t = 1 
svm.L2 = svm.regularization(X.train, y.train) 
bestCost = svm.L2(type=t, folds=10) 
# re-train best model with best cost value 
bestmod = LiblineaR(data=X.train, labels=y.train, type=t, cost=bestCost,  
bias=TRUE, verbose=FALSE) 
# make prediction 
ypred = predict(bestmod, X.test, proba=FALSE, decisionValues=TRUE) 
# Display confusion matrix 
( tbl = table(predict=ypred$predictions, truth=df.test$y) ) 
confusionMatrix(tbl) 
fitted = ypred$decisionValues[,1] 
( auc = rocplot(fitted, df.test$y,  
main="Linear SVM with L2 regularization: ColonCA Test Data") ) 
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APPENDIX G 
Training Neural Network classifier 
## Training NN classifier with Colon-cancer dataset  
> library(rpart) 
>gdf<- data.frame(ALL = colonCA_trainSub$class, t(exprs(colonCA_trainSub))) 
>   tr1 <- rpart(ALL ~ ., data = gdf) 
>   print(summary(tr1)) 
set.seed(100) 
library(nnet) 
gdf2<- df.train[, c(1, sample(2:ncol(df.train), size = 150))] 
nn1<- nnet(y~., data=df.train, size = 5, decay = 0.01, MaxNWts = 6131 
## Predict on training set 
> print(table(predict(nn1, type = "class"), y.train)) 
## Predict on test set 
> print(table(predict(nn1, new = df.test, 
+  type = "class"), y.test)) 
 
# confusionMatrix 
lvs<- c("n","t") 
truth <- factor(rep(lvs,times= c(11,7)),levels= rev(lvs)) 
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pred<- factor(c(rep(lvs,times= c(9,2)),rep(lvs,times= 
+ c(2,5))),levels= rev(lvs)) 
xtab<- table(pred, truth) 
confusionMatrix(xtab) 
# plot ROC Curve and calculate AUC  
fitted = attributes(pred)$decision.values 
( auc = rocplot(pred, truth, main="NN: ColonCA Test Data") ) 
 
## Training NN classifier with Breast-cancer dataset  
library(rpart) 
gdf<- data.frame(ALL = VEER1_train$class , t(exprs(VEER1_train))) 
> tr1 <- rpart(ALL ~ ., data = gdf) 
> print(summary(tr1)) 
> library(nnet) 
>  gdf2 <- gdf[, c(1, sample(2:ncol(gdf), size = 150))] 
> nn1 <- nnet(ALL ~ ., data = gdf2, size = 5, decay = 0.01, MaxNWts = 5000) 
## Predict on training set 
> print(table(predict(nn1, new = data.frame(t(exprs(VEER1_train))), 
+  type = "class"), VEER1_train$class))      
## Predict on test set 
(tbl = table(predict(nn1, new = data.frame(t(exprs(VEER1_test))), 
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+   type = "class"), VEER1_test$class)) 
# confusionMatrix 
>library(caret) 
>lvs<- c("n”,"t") 
>  truth <- factor(rep(lvs,times= c(13,27)),levels= rev(lvs)) 
>pred<- factor(c(rep(lvs,times= c(11,2)),rep(lvs,times=   c(0,27))),levels= rev(lvs)) 
>xtab<- table(pred, truth) 
>confusionMatrix(xtab) 
# plot ROC Curve and calculate AUC  
library(pROC) 
plot.roc(ypred, truth,main=" NN: VEER1 Test Data") 
## Training NN classifier with Prostate-cancer dataset  
> library(rpart) 
>gdf<- data.frame(ALL = singh2002$y, t(exprs(singh2002$ySub))) 
>   tr1 <- rpart(ALL ~ ., data = gdf) 
>   print(summary(tr1)) 
 
library(nnet) 
>  gdf2 <- gdf[, c(1, sample(2:ncol(gdf), size = 150))] 
> nn1 <- nnet(ALL ~ ., data = gdf2, size = 5, decay = 0.01, MaxNWts = 5000) 
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## Predict on training set 
> print(table(predict(nn1, type = "class"), df.train$y)) 
## Predict on test set 
> print(table(predict(nn1, new = data.frame(X.train), 
+  type = "class"), df.train$y)) 
# confusionMatrix 
> ( tbl = table(predict(nn1, type = "class"), df.train$y) )        
>confusionMatrix(tbl) 
Confusion Matrix and Statistics 
______________________________________________________________________________ 
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Appendix H 
Training K-Nearest Neighbor classifier 
## Training KNN classifier with Colon-cancer dataset  
> knn1 <- knn.cv(t(exprs(colonCA_trainSub)),colonCA_train$class, k = 1, prob = TRUE) 
>  print(table(knn1, colonCA_train$class)) 
 
 
 
sum(knn1 == colonCA_train$class)/length(colonCA_train$class) 
[1] 0.875 
> knn1 <- knn.cv(t(exprs(colonCA_trainSub)),colonCA_train$class, k = 2, prob = TRUE) 
>  print(table(knn1, colonCA_train$class)) 
 
 
 
 
> sum(knn1 == colonCA_train$class)/length(colonCA_train$class) 
[1] 0.875 
> knn1 <- knn.cv(t(exprs(colonCA_trainSub)),colonCA_train$class, k = 3, prob = TRUE) 
>  print(table(knn1, colonCA_train$class)) 
Knn1 n t n t 9 4 1 26 
Knn1 n t n t 8 5 1 26 
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> library(caret) 
lvs<- c("n","t") 
>  truth <- factor(rep(lvs,times= c(13,27)),levels= rev(lvs)) 
>pred<- factor(c(rep(lvs,times= c(9,4)),rep(lvs,times= c(0,27))),levels= rev(lvs)) 
>xtab<- table(pred, truth) 
>confusionMatrix(xtab) 
Confusion Matrix and Statistics 
 
                
 
Accuracy : 0.9              
                 95% CI : (0.7634, 0.9721) 
    No Information Rate : 0.675            
    P-Value [Acc> NIR] : 0.0009239        
                  Kappa : 0.7523           
Mcnemar's Test P-Value : 0.1336144        
            Sensitivity : 1.0000           
            Specificity : 0.6923           
Knn1 n t n t 9 4 1 26 
Knn1 n t n t 27 0 4 9 
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PosPred Value : 0.8710           
NegPred Value : 1.0000           
             Prevalence : 0.6750           
         Detection Rate : 0.6750           
   Detection Prevalence : 0.7750           
      Balanced Accuracy : 0.8462           
       'Positive' Class : t 
## Training KNN classifier with Leukemia cancer dataset  
> knn1 <- knn.cv(t(exprs(golubTrainSub)),gdf2$ALL, k = 1, prob = TRUE) 
>  print(table(knn1, Golub_Train$ALL)) 
 
 
    
 
sum(knn1 == golubTrainSub$ALL)/length(golubTrainSub$ALL) 
[1] 0.921 
> knn1 <- knn.cv(t(exprs(golubTrainSub)),gdf2$ALL, k = 2, prob = TRUE) 
>  print(table(knn1, Golub_Train$ALL)) 
 
 
 
Knn1 ALL AML ALL AML 27 0 3 8 
Knn1 ALL AML ALL AML 27 0 3 8 
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sum(knn1 == golubTrainSub$ALL)/length(golubTrainSub$ALL) 
[1] 0.921 
> knn1 <- knn.cv(t(exprs(golubTrainSub)),gdf2$ALL, k = 2, prob = TRUE) 
>  print(table(knn1, Golub_Train$ALL)) 
 
 
 
 
sum(knn1 == golubTrainSub$ALL)/length(golubTrainSub$ALL) 
[1] 0.89 
## Training KNN classifier with breast cancer dataset  
> knn1 <- knn.cv(X.test, y.test, k = 1, prob=TRUE) 
> print(table(knn1,y.test)) 
 
 
   
 
> knn1 <- knn.cv(X.test, y.test, k = 2, prob=TRUE) 
> print(table(knn1,y.test)) 
y.test 
Knn1 ALL AML ALL AML 26 1 3 8 
Knn1 DM NODM DM NODM 1 9 5 8 
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> knn1 <- knn.cv(X.test, y.test, k = 3, prob=TRUE) 
> print(table(knn1,y.test)) 
 
 
 
 
> ( tbl = table(predict=knn1, truth=df.test$y) ) 
 
 
    
 
>confusionMatrix(tbl) 
Confusion Matrix and Statistics 
 
 
    
              
 
Knn1 DM NODM DM NODM 2 8 5 8 
Knn1 DM NODM DM NODM 2 8 4 9 
Knn1 DM NODM DM NODM 2 8 4 9 
Knn1 DM NODM DM NODM 2 8 4 9 
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  Accuracy : 0.4783           
                 95% CI : (0.2682, 0.6941) 
    No Information Rate : 0.5652           
    P-Value [Acc> NIR] : 0.8534           
                  Kappa : -0.1129          
Mcnemar's Test P-Value : 0.3865           
            Sensitivity : 0.20000          
            Specificity : 0.69231          
PosPred Value : 0.33333          
NegPred Value : 0.52941          
             Prevalence : 0.43478          
         Detection Rate : 0.08696          
   Detection Prevalence : 0.26087          
      Balanced Accuracy : 0.44615          
       'Positive' Class : DM 
 
## Training KNN classifier with prostate cancer dataset  
> knn1 <- knn.cv(X.test, y.test, k=1, prob=TRUE) 
> print(table(knn1,y.test)) 
y.test 
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> knn1 <- knn.cv(X.test, y.test, k=2, prob=TRUE) 
> print(table(knn1,y.test)) 
 
 
 
 
> knn1 <- knn.cv(X.test, y.test, k=3, prob=TRUE) 
> print(table(knn1,y.test)) 
 
   
 
 
> ( tbl = table(knn1, truth=df.test$y) ) 
 
 
 
>confusionMatrix(tbl) 
Knn1 cancer healthy 
cancer  
healthy 12 6 5 7 
Knn1 cancer healthy 
cancer  
healthy 12 6 7 5 
Knn1 cancer healthy 
cancer  
healthy 15 3 8 4 
Knn1 cancer healthy 
cancer  
healthy 12 6 5 7 
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Confusion Matrix and Statistics 
 
   
                
 
Accuracy : 0.6333           
                 95% CI : (0.4386, 0.8007) 
    No Information Rate : 0.6              
    P-Value [Acc> NIR] : 0.4311           
                  Kappa : 0.2466           
Mcnemar's Test P-Value : 1.0000           
            Sensitivity : 0.6667           
            Specificity : 0.5833           
PosPred Value : 0.7059           
NegPred Value : 0.5385           
             Prevalence : 0.6000           
         Detection Rate : 0.4000           
   Detection Prevalence : 0.5667           
      Balanced Accuracy : 0.6250           
       'Positive' Class : cancer 
Knn1 cancer healthy 
cancer  
healthy 12 6 5 7 
